This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Holmstedt B. Structure-activity relationships of the organophosphorus anticholinesterase agents. In: Koelle GB, editor. Cholinesterases and anticholinesterase agents. Berlin: Springer-Verlag; 1963. p. 428–85.HolmstedtBStructure-activity relationships of the organophosphorus anticholinesterase agentsInKoelleGBeditorBerlinSpringer-Verlag1963p4288510.1007/978-3-642-99875-1_9Search in Google Scholar
Chambers HW. Organophosphorus compounds: an overview. In: Chambers JE, Levi PE, editors. Organophosphates: chemistry, fate, and effects. San Diego: Academic Press; 1992. p. 3-17.ChambersHWOrganophosphorus compounds: an overviewInChambersJELeviPEeditorsSan DiegoAcademic Press1992p31710.1016/B978-0-08-091726-9.50005-7Search in Google Scholar
Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet 2008;371:597–607. doi: 10.1016/S0140-6736(07)61202-1EddlestonMBuckleyNAEyerPDawsonAHManagement of acute organophosphorus pesticide poisoning2008371597607doi10.1016/S0140-6736(07)61202-1Open DOISearch in Google Scholar
Kaur HG, Garg H. Pesticides: environmental impacts and management strategies. In: Larramendy ML, Soloneski S, editors. Pesticides - toxic aspects. London: IntechOpen; 2014. p. 187–229. doi: 10.5772/57399KaurHGGargHPesticides: environmental impacts and management strategiesInLarramendyMLSoloneskiSeditorsLondonIntechOpen2014p187229doi10.5772/57399Open DOISearch in Google Scholar
Dolgin E. Syrian gas attack reinforces need for better anti-sarin drugs. Nat Med 2013;19:1194–5. doi: 10.1038/nm1013-1194DolginESyrian gas attack reinforces need for better anti-sarin drugs20131911945doi10.1038/nm1013-119424100968Open DOISearch in Google Scholar
Stone R. U.K. attack puts nerve agent in the spotlight. Science 2018;359:1314–5. doi: 10.1126/science.359.6382.1314StoneR. U.Kattack puts nerve agent in the spotlight201835913145doi10.1126/science.359.6382.131429567684Open DOISearch in Google Scholar
Bakry NM, el-Rashidy AH, Eldefrawi AT, Eldefrawi ME. Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors. J Biochem Toxicol 1988;3:235–59. doi: 10.1002/jbt.2570030404BakryNMel-RashidyAHEldefrawiATEldefrawiMEDirect actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors1988323559doi10.1002/jbt.25700304043236334Open DOISearch in Google Scholar
Wiener SW, Hoffman RS. Nerve agents: a comprehensive review. J Intensive Care Med 2004;19:22–37. doi: 10.1177/0885066603258659WienerSWHoffmanRSNerve agents: a comprehensive review2004192237doi10.1177/088506660325865915035752Open DOISearch in Google Scholar
Costa LG. Toxicology of pesticides: a brief history. In: Costa LG, Galli CL, Murphy SD, editors. Toxicology of pesticides: experimental, clinical, and regulatory perspectives, NATO ASI Series. Vol. 13. Berlin-Heidelberg: Springer; 1987. p. 1–10.CostaLGToxicology of pesticides: a brief historyInCostaLGGalliCLMurphySDeditorsBerlin-HeidelbergSpringer1987p11010.1007/978-3-642-70898-5Search in Google Scholar
Tucker JB. War of Nerves: Chemical Warfare from World War I to Al-Qaeda. New York: Anchor; 2007.TuckerJBNew YorkAnchor2007Search in Google Scholar
Delfino RT, Ribeiro TS, Figueroa-Villar JD. Organophosphorus compounds as chemical warfare agents: a review. J Braz Chem Soc 2009;20:407–28. doi: 10.1590/S0103-50532009000300003DelfinoRTRibeiroTSFigueroa-VillarJDOrganophosphorus compounds as chemical warfare agents: a review20092040728doi10.1590/S0103-50532009000300003Open DOISearch in Google Scholar
Sidell FR. Nerve agents. In: Sidell FR, Takafuji ET, Franz DR, editors. Medical aspects of chemical and biological warfare. Textbook of military medicine. Washington (DC): Office of the Surgeon General, Department of the Army USA; 1997. p. 129–79.SidellFRNerve agentsInSidellFRTakafujiETFranzDReditorsWashington (DC)Office of the Surgeon General, Department of the Army USA1997p1297910.21236/ADA398241Search in Google Scholar
Hoenig SL. Nerve agents. In: Compendium of chemical warfare agents. New York (NY): Springer; 2007. p. 77–128. doi: 10.1007/978-0-387-69260-9_5HoenigSLNerve agentsInNew York (NY)Springer2007p77128doi10.1007/978-0-387-69260-9_5Open DOISearch in Google Scholar
Pitschmann V. Overall view of chemical and biochemical weapons. Toxins (Basel) 2014;6:1761–84. doi: 10.3390/toxins6061761PitschmannVOverall view of chemical and biochemical weapons20146176184doi10.3390/toxins6061761Open DOISearch in Google Scholar
Vásárhelyi G, Földi L. History of Russia’s chemical weapons. AARMS 2007;6:135–46.VásárhelyiGFöldiLHistory of Russia’s chemical weapons2007613546Search in Google Scholar
Carlsen L. After Salisbury nerve agents revised. Mol Inform 2019;38(8–9):e1800106. doi: 10.1002/minf.201800106CarlsenLAfter Salisbury nerve agents revised2019388–9e1800106doi10.1002/minf.201800106Open DOISearch in Google Scholar
Pita R, Domingo J. The use of chemical weapons in the Syrian conflict. Toxics 2014;2:391–402. doi: 10.3390/toxics2030391PitaRDomingoJThe use of chemical weapons in the Syrian conflict20142391402doi10.3390/toxics2030391Open DOISearch in Google Scholar
Balali-Mood M, Saber H. Recent advances in the treatment of organophosphorous poisonings. Iran J Med Sci 2012;37:74–91. PMCID: PMC3470074Balali-MoodMSaberHRecent advances in the treatment of organophosphorous poisonings2012377491PMCID: PMC3470074Search in Google Scholar
Timperley C, Forman J, Aas P, Abdollahi M, Benachour D, Al-Amri A, Baulig A, Becker-Arnold R, Borrett V, Carino FA, Curty C, Gonzalez D, Geist M, Kane W, Kovarik Z, Martínez-Alvarez R, Mikulak R, Mourao N, Neffe S, Izzati F. Advice from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons on riot control agents in connection to the Chemical Weapons Convention. RSC Advances 2018;8:41731–9. doi: 10.1039/C8RA08273ATimperleyCFormanJAasPAbdollahiMBenachourDAl-AmriABauligABecker-ArnoldRBorrettVCarinoFACurtyCGonzalezDGeistMKaneWKovarikZMartínez-AlvarezRMikulakRMouraoNNeffeSIzzatiFAdvice from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons on riot control agents in connection to the Chemical Weapons Convention20188417319doi10.1039/C8RA08273AOpen DOISearch in Google Scholar
John H, van der Schans MJ, Koller M, Spruit HET, Worek F, Thiermann H, Noort D. Fatal sarin poisoning in Syria 2013: forensic verification within an international laboratory network. Forensic Toxicol 2018;36:61–71. doi: 10.1007/s11419-017-0376-7JohnHvan der SchansMJKollerMSpruitHETWorekFThiermannHNoortDFatal sarin poisoning in Syria 2013: forensic verification within an international laboratory network2018366171doi10.1007/s11419-017-0376-7Open DOISearch in Google Scholar
Shwirtz M. Nerve agent was used to poison Navalny, chemical weapons body confirms. The New York Times online [displayed 22 November 2020]. Available at https://www.nytimes.com/2020/10/06/world/europe/navalny-opcw-russia-novichok.htmlShwirtzMNerve agent was used to poison Navalny, chemical weapons body confirmsonline [displayed 22 November 2020]. Available athttps://www.nytimes.com/2020/10/06/world/europe/navalny-opcw-russia-novichok.htmlSearch in Google Scholar
Organisation for the Prohibition of Chemical Weapons (OPCW). OPCW issues report on technical assistance requested by Germany [displayed 22 November 2020]. Available at https://www.opcw.org/media-centre/news/2020/10/opcw-issues-report-technical-assistance-requested-germanyOrganisation for the Prohibition of Chemical Weapons (OPCW)[displayed 22 November 2020]. Available athttps://www.opcw.org/media-centre/news/2020/10/opcw-issues-report-technical-assistance-requested-germanySearch in Google Scholar
Jokanović M, Stojiljković MP. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning. Eur J Pharmacol 2006;553:10–17. doi: 10.1016/j. ejphar.2006.09.054JokanovićMStojiljkovićMPCurrent understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning20065531017doi10.1016/j.ejphar.2006.09.054Open DOISearch in Google Scholar
Bucht G, Puu G. Aging and reactivatability of plaice cholinesterase inhibited by soman and its stereoisomers. Biochem Pharmacol 1984;33:3573–7. doi: 10.1016/0006-2952(84)90139-4BuchtGPuuGAging and reactivatability of plaice cholinesterase inhibited by soman and its stereoisomers19843335737doi10.1016/0006-2952(84)90139-4Open DOISearch in Google Scholar
Benschop HP, De Jong, LPA. Nerve agent stereoisomers: analysis isolation and toxicology. Acc Chem Res 1988;21:368–74. doi: 10.1021/ar00154a003BenschopHPDe JongLPANerve agent stereoisomers: analysis isolation and toxicology19882136874doi10.1021/ar00154a003Open DOISearch in Google Scholar
Worek F, Koller M, Thiermann H, Szinicz L. Diagnostic aspects of organophosphate poisoning. Toxicology 2005;214:182–9. doi: 10.1016/j.tox.2005.06.012WorekFKollerMThiermannHSziniczLDiagnostic aspects of organophosphate poisoning20052141829doi10.1016/j.tox.2005.06.01216051411Open DOISearch in Google Scholar
Quin DM. Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transitions states. Chem Rev 1987;78:955–79. doi: 10.1021/cr00081a005QuinDMAcetylcholinesterase: enzyme structure, reaction dynamics, and virtual transitions states19877895579doi10.1021/cr00081a005Open DOISearch in Google Scholar
Taylor P, Radić Z. The cholinesterases: from genes to proteins. Annu Rev Pharmacol Toxicol 1994;34:281–320. doi: 10.1146/annurev.pa.34.040194.001433TaylorPRadićZThe cholinesterases: from genes to proteins199434281320doi10.1146/annurev.pa.34.040194.0014338042853Open DOISearch in Google Scholar
Bourne Y, Taylor P, Bougis PE, Marchot P. Crystal structure of mouse acetylcholinesterase. A peripheral site-occluding loop in a tetrameric assembly. J Biol Chem 1999;274:2963–70. doi: 10.1074/jbc.274.5.2963BourneYTaylorPBougisPEMarchotPCrystal structure of mouse acetylcholinesterase. A peripheral site-occluding loop in a tetrameric assembly1999274296370doi10.1074/jbc.274.5.29639915834Open DOISearch in Google Scholar
Silman I, Sussman JL. Acetylcholinesterase: how is structure related to function? Chem Biol Interact 2008;175:3–10. doi: 10.1016/j.cbi.2008.05.035SilmanISussmanJLAcetylcholinesterase: how is structure related to function?2008175310doi10.1016/j.cbi.2008.05.03518586019Open DOISearch in Google Scholar
Sanson B, Colletier JP, Xu Y, Lang PT, Jiang H, Silman I, Sussman JL, Weik M. Backdoor opening mechanism in acetylcholinesterase based on X-ray crystallography and molecular dynamics simulations. Protein Sci 2011;20:1114–8. doi: 10.1002/pro.661SansonBColletierJPXuYLangPTJiangHSilmanISussmanJLWeikMBackdoor opening mechanism in acetylcholinesterase based on X-ray crystallography and molecular dynamics simulations20112011148doi10.1002/pro.661314918421594947Open DOISearch in Google Scholar
Çokuğras AN. Butyrylcholinesterase: structure and physiological importance. Turk J Biochem 2003;28:54–61.ÇokuğrasANButyrylcholinesterase: structure and physiological importance2003285461Search in Google Scholar
Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J Biol Chem 2003;278:41141–7. doi: 10.1074/jbc.M210241200NicoletYLockridgeOMassonPFontecilla-CampsJCNachonFCrystal structure of human butyrylcholinesterase and of its complexes with substrate and products2003278411417doi10.1074/jbc.M21024120012869558Open DOISearch in Google Scholar
Chatonnet A, Lockridge O. Comparison of butyrylcholinesterase and acetylcholinesterase. Biochem J 1989;260:625–34. doi: 10.1042/bj2600625ChatonnetALockridgeOComparison of butyrylcholinesterase and acetylcholinesterase198926062534doi10.1042/bj260062511387242669736Open DOISearch in Google Scholar
Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 2003;4:131–8. doi: 10.1038/nrn1035DarveshSHopkinsDAGeulaCNeurobiology of butyrylcholinesterase200341318doi10.1038/nrn103512563284Open DOISearch in Google Scholar
Grisaru D, Sternfeld M, Eldor A, Glick D, Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem 1999;264:672–86. doi: 10.1046/j.1432-1327.1999.00693.xGrisaruDSternfeldMEldorAGlickDSoreqHStructural roles of acetylcholinesterase variants in biology and pathology199926467286doi10.1046/j.1432-1327.1999.00693.x10491113Open DOISearch in Google Scholar
Soreq H, Seidman S. Acetylcholinesterase-new roles for an old actor. Nat Rev Neurosci 2001;2:294–302. doi: 10.1038/35067589SoreqHSeidmanSAcetylcholinesterase-new roles for an old actor20012294302doi10.1038/35067589Open DOISearch in Google Scholar
Bosak A, Gazić I, Vinković V, Kovarik Z. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers. Chem Biol Interact 2008;175:192–5. doi: 10.1016/j.cbi.2008.04.050BosakAGazićIVinkovićVKovarikZStereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers20081751925doi10.1016/j.cbi.2008.04.050Open DOISearch in Google Scholar
Xie W, Stribley JA, Chatonnet A, Wilder PJ, Rizzino A, McComb RD, Taylor P, Hinrichs SH, Lockridge O. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J Pharmacol Exp Ther 2000;293:896–902. PMID: 10869390XieWStribleyJAChatonnetAWilderPJRizzinoAMcCombRDTaylorPHinrichsSHLockridgeOPostnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase2000293896902PMID: 10869390Search in Google Scholar
Bajgar J. Prophylaxis against organophosphorus poisoning. J Med Chem Def 2004;1:1–16.BajgarJProphylaxis against organophosphorus poisoning20041116Search in Google Scholar
Newmark J. Therapy for nerve agent poisoning. Arch Neurol 2004;61:649–52. doi: 10.1001/archneur.61.5.649NewmarkJTherapy for nerve agent poisoning20046164952doi10.1001/archneur.61.5.649Open DOISearch in Google Scholar
Hobbiger F. Reactivation of phosphorylated acetylcholinesterase. In: Koelle GB, editor. Cholinesterases and anticholinesterase agents. Handbook of experimental pharmacology. Vol. 15. Berlin, Heidelberg: Springer; 1963. p. 921–88.HobbigerFReactivation of phosphorylated acetylcholinesteraseInKoelleGBeditorBerlin, HeidelbergSpringer1963p9218810.1007/978-3-642-99875-1_21Search in Google Scholar
Holmstedt B. Cholinesterase inhibitors: an introduction. In: Giacobini E, editor. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz Ltd; 2000. p. 1–8.HolmstedtBCholinesterase inhibitors: an introductionInGiacobiniEeditorLondonMartin Dunitz Ltd2000p18Search in Google Scholar
Benschop HP, Konings CA, Van Genderen J, De Jong LP. Isolation, anticholinesterase properties, and acute toxicity in mice of the four stereoisomers of the nerve agent soman. Toxicol Appl Pharmacol 1984;72:61–74. doi: 10.1016/0041-008x(84)90249-7BenschopHPKoningsCAVan GenderenJDe JongLPIsolation, anticholinesterase properties, and acute toxicity in mice of the four stereoisomers of the nerve agent soman1984726174doi10.1016/0041-008x(84)90249-7Open DOISearch in Google Scholar
Reiner E, Radić Z. Mechanism of action of cholinesterase inhibitor. In: Giacobini E, editor. Cholinesterases and cholinesterase inhibitors. London: Martin Dunitz Ltd; 2000. p. 103–19.ReinerERadićZMechanism of action of cholinesterase inhibitorInGiacobiniEeditorLondonMartin Dunitz Ltd2000p10319Search in Google Scholar
Bosak A, Katalinić M, Kovarik Z. Kolinesteraze: struktura, uloga, inhibicija [Cholinesterases: structure, role, and inhibition, in Croatian]. Arh Hig Rada Toksikol 2011;62:175–90. doi: 10.2478/10004-1254-62-2011-2107BosakAKatalinićMKovarikZKolinesteraze: struktura, uloga, inhibicija [Cholinesterases: structure, role, and inhibition, in Croatian]20116217590doi10.2478/10004-1254-62-2011-210721705306Open DOISearch in Google Scholar
Millard CB, Koellner G, Ordentlich A, Shafferman A, Silman I, Sussman JL. Reaction products of acetylcholinesterase and VX reveal a mobile histidine in the catalytic triad. J Am Chem Soc 1999;121:9883–4. doi: 10.1021/ja992704iMillardCBKoellnerGOrdentlichAShaffermanASilmanISussmanJLReaction products of acetylcholinesterase and VX reveal a mobile histidine in the catalytic triad199912198834doi10.1021/ja992704iOpen DOISearch in Google Scholar
Ekström F, Akfur C, Tunemalm AK, Lundberg S. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase. Biochemistry 2006;45:74–81. doi: 10.1021/bi051286tEkströmFAkfurCTunemalmAKLundbergSStructural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase2006457481doi10.1021/bi051286t16388582Open DOISearch in Google Scholar
Masson P, Nachon F, Lockridge O. Structural approach to the aging of phosphylated cholinesterases. Chem Biol Interact 2010;187:157–62. doi: 10.1016/j.cbi.2010.03.027MassonPNachonFLockridgeOStructural approach to the aging of phosphylated cholinesterases201018715762doi10.1016/j.cbi.2010.03.02720338153Open DOISearch in Google Scholar
Chandar NB, Ganguly B. A first principles investigation of aging processes in soman conjugated AChE. Chem Biol Interact 2013;204:185–90. doi: 10.1016/j.cbi.2013.05.013ChandarNBGangulyBA first principles investigation of aging processes in soman conjugated AChE201320418590doi10.1016/j.cbi.2013.05.01323747845Open DOISearch in Google Scholar
de Jong LP, Wolring GZ. Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species including man, inhibited by soman. Biochem Pharmacol 1984;33:1119–25. doi: 10.1016/0006-2952(84)90523-9de JongLPWolringGZStereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species including man, inhibited by soman198433111925doi10.1016/0006-2952(84)90523-9Open DOISearch in Google Scholar
Worek F, Thiermann H, Szinicz L, Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 2004;68:2237–48. doi: 10.1016/j.bcp.2004.07.038WorekFThiermannHSziniczLEyerPKinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes200468223748doi10.1016/j.bcp.2004.07.038Open DOISearch in Google Scholar
Zhuang Q, Franjesevic AJ, Corrigan TS, Coldren WH, Dicken R, Sillart S, DeYong A, Yoshino N, Smith J, Fabry S, Fitzpatrick K, Blanton TG, Joseph J, Yoder RJ, McElroy CA, Ekici ÖD, Callam CS, Hadad CM. Demonstration of in vitro resurrection of aged acetylcholinesterase after exposure to organophosphorus chemical nerve agents. J Med Chem 2018;61:7034–42. doi: 10.1021/acs.jmedchem.7b01620ZhuangQFranjesevicAJCorriganTSColdrenWHDickenRSillartSDeYongAYoshinoNSmithJFabrySFitzpatrickKBlantonTGJosephJYoderRJMcElroyCAEkiciÖDCallamCSHadadCMDemonstration of in vitro resurrection of aged acetylcholinesterase after exposure to organophosphorus chemical nerve agents201861703442doi10.1021/acs.jmedchem.7b01620Open DOISearch in Google Scholar
Shih TM, Rowland TC, McDonough JH. Anticonvulsants for nerve agentinduced seizures: the influence of the therapeutic dose of atropine. J Pharmacol Exp Ther 2007;320:154–61. doi: 10.1124/jpet.106.111252ShihTMRowlandTCMcDonoughJHAnticonvulsants for nerve agentinduced seizures: the influence of the therapeutic dose of atropine200732015461doi10.1124/jpet.106.111252Open DOISearch in Google Scholar
Thiermann H, Steinritz D, Worek F, Radtke B, Eyer P, Eyer F, Felgenhauer N, Zilker T. Atropine maintenance dosage in patients with severe organophosphate pesticide poisoning. Toxicol Lett 2011;206:77–83. doi: 10.1016/j. toxlet.2011.07.006ThiermannHSteinritzDWorekFRadtkeBEyerPEyerFFelgenhauerNZilkerTAtropine maintenance dosage in patients with severe organophosphate pesticide poisoning20112067783doi10.1016/j.toxlet.2011.07.006Open DOISearch in Google Scholar
Sidell FR, Newmark J, McDonough JH. Nerve agents. In: Lenhart MK, Tuorinsky SD, editors. Textbooks of military medicine, medical aspects of chemical warfare. Washington (DC): Department of the Army USA; 2008. p. 155–219.SidellFRNewmarkJMcDonoughJHNerve agentsInLenhartMKTuorinskySDeditorsWashington (DC)Department of the Army USA2008p155219Search in Google Scholar
Childs AF, Davies DR, Green AL, Rutland JP. The reactivation by oximes and hydroxamic acids of cholinesterase inhibited by organo-phosphorus compounds. Br J Pharmacol Chemother 1955;10:462–5. doi: 10.1111/j.1476-5381.1955. tb00106.xChildsAFDaviesDRGreenALRutlandJPThe reactivation by oximes and hydroxamic acids of cholinesterase inhibited by organo-phosphorus compounds1955104625doi10.1111/j.1476-5381.1955.tb00106.xOpen DOISearch in Google Scholar
Wilson IB, Ginsburg S. Reactivation of acetylcholinesterase inhibited by alkylphosphates. Arch Biochem Biophys 1955;54:569–71. doi: 10.1016/0003-9861(55)90075-8WilsonIBGinsburgSReactivation of acetylcholinesterase inhibited by alkylphosphates19555456971doi10.1016/0003-9861(55)90075-8Open DOISearch in Google Scholar
Rousseaux CG, Dua AK. Pharmacology of HI-6, an H-series oxime. Can J Physiol Pharmacol 1989;67:1183–9. doi: 10.1139/y89-188RousseauxCGDuaAKPharmacology of HI-6, an H-series oxime19896711839doi10.1139/y89-1882692793Open DOISearch in Google Scholar
Eyer P. In memory of Ilse Hagedorn. Toxicology 2007;233:3–7. doi: 10.1016/j.tox.2006.09.014EyerPIn memory of Ilse Hagedorn200723337doi10.1016/j.tox.2006.09.01417511052Open DOISearch in Google Scholar
Worek F, Thiermann H, Wille T. Oximes in organophosphate poisoning: 60 years of hope and despair. Chem Biol Interact 2016;259(Pt B):93–8. doi: 10.1016/j.cbi.2016.04.032WorekFThiermannHWilleTOximes in organophosphate poisoning: 60 years of hope and despair2016259Pt B938doi10.1016/j.cbi.2016.04.03227125761Open DOISearch in Google Scholar
Dawson RM. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 1994;14:317–31. doi: 10.1002/jat.2550140502DawsonRMReview of oximes available for treatment of nerve agent poisoning19941431731doi10.1002/jat.2550140502Open DOISearch in Google Scholar
Antonijević B, Stojiljković MP. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res 2007;5:71–82. doi: 10.3121/cmr.2007.701AntonijevićBStojiljkovićMPUnequal efficacy of pyridinium oximes in acute organophosphate poisoning200757182doi10.3121/cmr.2007.701Open DOISearch in Google Scholar
Thiermann H, Worek F, Kehe K. Limitations and challenges in treatment of acute chemical warfare agent poisoning. Chem Biol Interact 2013;206:435–43. doi: 10.1016/j. cbi.2013.09.015ThiermannHWorekFKeheKLimitations and challenges in treatment of acute chemical warfare agent poisoning201320643543doi10.1016/j.cbi.2013.09.015Open DOISearch in Google Scholar
Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, Felgenhauer N, Zilker T. Modern strategies in therapy of organophosphate poisoning. Toxicol Lett 1999;107:233–9. doi: 10.1016/s0378-4274(99)00052-1ThiermannHSziniczLEyerFWorekFEyerPFelgenhauerNZilkerTModern strategies in therapy of organophosphate poisoning19991072339doi10.1016/s0378-4274(99)00052-1Open DOISearch in Google Scholar
Worek F, Szinicz L, Eyer P, Thiermann H. Evaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model. Toxicol Appl Pharmacol 2005;209:193–202. doi: 10.1016/j.taap.2005.04.006WorekFSziniczLEyerPThiermannHEvaluation of oxime efficacy in nerve agent poisoning: development of a kinetic-based dynamic model2005209193202doi10.1016/j.taap.2005.04.00615904945Open DOISearch in Google Scholar
Lorke DE, Kalasz H, Petroianu GA, Tekes K. Entry of oximes into the brain: a review. Curr Med Chem 2008;15:743–53. doi: 10.2174/092986708783955563LorkeDEKalaszHPetroianuGATekesKEntry of oximes into the brain: a review20081574353doi10.2174/09298670878395556318393843Open DOISearch in Google Scholar
Kovarik Z, Radić Z, Berman HA, Simeon-Rudolf V, Reiner E, Taylor P. Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates. Biochemistry 2004;43:3222–9. doi: 10.1021/bi036191aKovarikZRadićZBermanHASimeon-RudolfVReinerETaylorPMutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates20044332229doi10.1021/bi036191a15023072Open DOISearch in Google Scholar
Kovarik Z, Čalić M, Šinko G, Bosak A, Berend S, Lucić Vrdoljak A, Radić B. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. Chem Biol Interact 2008;175:173–9. doi: 10.1016/j.cbi.2008.04.011KovarikZČalićMŠinkoGBosakABerendSLucić VrdoljakARadićBOximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning20081751739doi10.1016/j.cbi.2008.04.01118501341Open DOISearch in Google Scholar
Kovarik Z, Katalinić M, Šinko G, Binder J, Holas O, Jung YS, Musilova L, Jun D, Kuča K. Pseudo-catalytic scavenging: Searching for a suitable reactivator of phosphorylated butyrylcholinesterase. Chem Biol Interact 2010;187:167–71. doi: 10.1016/j.cbi.2010.02.023KovarikZKatalinićMŠinkoGBinderJHolasOJungYSMusilovaLJunDKučaKPseudo-catalytic scavenging: Searching for a suitable reactivator of phosphorylated butyrylcholinesterase201018716771doi10.1016/j.cbi.2010.02.02320206154Open DOISearch in Google Scholar
Kovarik Z, Maček Hrvat N, Katalinić M, Sit RK, Paradyse A, Žunec S, Musilek K, Fokin VV, Taylor P, Radić Z. Catalytic soman scavenging by the Y337A/F338A acetylcholinesterase mutant assisted with novel site-directed aldoximes. Chem Res Toxicol 2015;28:1036–44. doi: 10.1021/acs.chemrestox.5b00060KovarikZMaček HrvatNKatalinićMSitRKParadyseAŽunecSMusilekKFokinVVTaylorPRadićZCatalytic soman scavenging by the Y337A/F338A acetylcholinesterase mutant assisted with novel site-directed aldoximes201528103644doi10.1021/acs.chemrestox.5b00060479109825835984Open DOISearch in Google Scholar
Worek F, Reiter G, Eyer P, Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol 2002;76:523–9. doi: 10.1007/s00204-002-0375-1WorekFReiterGEyerPSziniczLReactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates2002765239doi10.1007/s00204-002-0375-112242610Open DOISearch in Google Scholar
Ekström F, Pang YP, Boman M, Artursson E, Akfur C, Börjegren S. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates. Biochem Pharmacol 2006;72:597–607. doi: 10.1016/j. bcp.2006.05.027EkströmFPangYPBomanMArturssonEAkfurCBörjegrenSCrystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates200672597607doi10.1016/j.bcp.2006.05.02716876764Open DOISearch in Google Scholar
Kovarik Z, Kalisiak J, Maček Hrvat N, Katalinić M, Zorbaz T, Žunec S, Green C, Radić Z, Fokin VV, Sharpless KB, Taylor P. Reversal of tabun toxicity enabled by a triazole annulated oxime library-reactivators of acetylcholinesterase. Chem Eur J 2019;25:4100–14. doi: 10.1002/chem.201805051KovarikZKalisiakJMaček HrvatNKatalinićMZorbazTŽunecSGreenCRadićZFokinVVSharplessKBTaylorPReversal of tabun toxicity enabled by a triazole annulated oxime library-reactivators of acetylcholinesterase201925410014doi10.1002/chem.20180505130458057Open DOISearch in Google Scholar
Kovarik Z, Ciban N, Radić Z, Simeon-Rudolf V, Taylor P. Active site mutant acetylcholinesterase interactions with 2-PAM, HI-6, and DDVP. Biochem Biophys Res Commun 2006;342(3):973–8. doi: 10.1016/j.bbrc.2006.02.056KovarikZCibanNRadićZSimeon-RudolfVTaylorPActive site mutant acetylcholinesterase interactions with 2-PAM, HI-6, and DDVP200634239738doi10.1016/j.bbrc.2006.02.05616598855Open DOISearch in Google Scholar
de Koning MC, Joosen MJ, Noort D, van Zuylen A, Tromp MC. Peripheral site ligand-oxime conjugates: A novel concept towards reactivation of nerve agent-inhibited human acetylcholinesterase. Bioorg Med Chem 2011;19:588–94. doi: 10.1016/j.bmc.2010.10.059de KoningMCJoosenMJNoortDvan ZuylenATrompMCPeripheral site ligand-oxime conjugates: A novel concept towards reactivation of nerve agent-inhibited human acetylcholinesterase20111958894doi10.1016/j.bmc.2010.10.05921112787Open DOISearch in Google Scholar
Maraković N, Knežević A, Vinković V, Kovarik Z, Šinko G. Design and synthesis of N -substituted-2-hydroxyiminoacetamides and interactions with cholinesterases. Chem Biol Interact 2016;259:122–32. doi: 10.1016/j.cbi.2016.05.035MarakovićNKneževićAVinkovićVKovarikZŠinkoGDesign and synthesis of N -substituted-2-hydroxyiminoacetamides and interactions with cholinesterases201625912232doi10.1016/j.cbi.2016.05.03527238725Open DOISearch in Google Scholar
Kovarik Z, Maček Hrvat N, Kalisiak J, Katalinić M, Sit RK, Zorbaz T, Radić Z, Fokin VV, Sharpless KB, Taylor P. Counteracting tabun inhibition by reactivation by pyridinium aldoximes interacting with active center gorge mutations of acetylcholinesterase. Toxicol Appl Pharmacol 2019;372:40–6. doi: 10.1016/j.taap.2019.04.007KovarikZMaček HrvatNKalisiakJKatalinićMSitRKZorbazTRadićZFokinVVSharplessKBTaylorPCounteracting tabun inhibition by reactivation by pyridinium aldoximes interacting with active center gorge mutations of acetylcholinesterase2019372406doi10.1016/j.taap.2019.04.00730978400Open DOISearch in Google Scholar
Maček Hrvat N, Kalisiak J, Šinko G, Radić Z, Sharpless KB, Taylor P, Kovarik Z. Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases. Toxicol Lett 2020;321:83–9. doi: 10.1016/j.toxlet.2019.12.016Maček HrvatNKalisiakJŠinkoGRadićZSharplessKBTaylorPKovarikZEvaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases2020321839doi10.1016/j.toxlet.2019.12.016705343131863869Open DOISearch in Google Scholar
Primožič I, Odžak R, Tomić S, Simeon-Rudolf V, Reiner E. Pyridinium, imidazolium, and quinucludinium oximes: synthesis, interaction with native and phosphylated cholinesterases, and antidotes against organophosphorus compounds. J Med Chem Def 2004;2:1–30.PrimožičIOdžakRTomićSSimeon-RudolfVReinerEPyridinium, imidazolium, and quinucludinium oximes: synthesis, interaction with native and phosphylated cholinesterases, and antidotes against organophosphorus compounds20042130Search in Google Scholar
Oh KA, Yang GY, Jun D, Kuca K, Jung YS. Bispyridiumaldoxime reactivators connected with CH2O(CH2 n OCH2 linkers between pyridinium rings and their reactivity against VX. Bioorg Med Chem Lett 2006;16:4852–5. doi: 10.1016/j.bmcl.2006.06.063OhKAYangGYJunDKucaKJungYSBispyridiumaldoxime reactivators connected with CH2O(CH2 n OCH2 linkers between pyridinium rings and their reactivity against VX20061648525doi10.1016/j.bmcl.2006.06.06316828550Open DOISearch in Google Scholar
Musilek K, Holas O, Jun D, Dohnal V, Gunn-Moore F, Opletalova V, Dolezal M, Kuca K. Monooxime reactivators of acetylcholinesterase with E-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase. Bioorg Med Chem 2007;15:6733–41. doi: 10.1016/j.bmc.2007.08.002MusilekKHolasOJunDDohnalVGunn-MooreFOpletalovaVDolezalMKucaKMonooxime reactivators of acetylcholinesterase with E-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase200715673341doi10.1016/j.bmc.2007.08.00217764957Open DOISearch in Google Scholar
Acharya J, Dubey DK, Srivastava AK, Raza SK. In vitro reactivation of sarin-inhibited human acetylcholinesterase (AChE) by bis-pyridinium oximes connected by xylene linkers. Toxicol In Vitro 2011;25:251–6. doi: 10.1016/j. tiv.2010.07.024AcharyaJDubeyDKSrivastavaAKRazaSK.In vitro reactivation of sarin-inhibited human acetylcholinesterase (AChE) by bis-pyridinium oximes connected by xylene linkers2011252516doi10.1016/j.tiv.2010.07.024Open DOISearch in Google Scholar
Čalić M, Bosak A, Šinko G, Jelić D. In vitro evaluation of aldoxime interactions with human acetylcholinesterase. Croat Chem Acta 2008;81:47–57.ČalićMBosakAŠinkoGJelićDIn vitro evaluation of aldoxime interactions with human acetylcholinesterase2008814757Search in Google Scholar
Kryger G, Silman I, Sussman JL. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Structure 1999;7:297–307. doi: 10.1016/s0969-2126(99)80040-9KrygerGSilmanISussmanJLStructure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs19997297307doi10.1016/s0969-2126(99)80040-9Open DOISearch in Google Scholar
McHardy SF, Bohmann JA, Corbett MR, Campos B, Tidwell MW, Thompson PM, Bemben CJ, Menchaca TA, Reeves TE, Cantrell WRJr, Bauta WE, Lopez A, Maxwell DM, Brecht KM, Sweeney RE, McDonough J. Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase. Bioorg Med Chem Lett 2014;24:1711–4. doi: 10.1016/j.bmcl.2014.02.049McHardySFBohmannJACorbettMRCamposBTidwellMWThompsonPMBembenCJMenchacaTAReevesTECantrellWRJrBautaWELopezAMaxwellDMBrechtKMSweeneyREMcDonoughJDesign, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase20142417114doi10.1016/j.bmcl.2014.02.04924630558Open DOISearch in Google Scholar
Renou J, Dias J, Mercey G, Verdelet T, Rousseau C, Gastellier A-J, Arboleas M, Touvrey-Loiodice M, Baati R, Jean L, Nachon F, Renard P-Y. Synthesis and in vitro evaluation of donepezil- based reactivators and analogues for nerve agent-inhibited human acetylcholinesterase. RSC Adv 2016;6:17929–40. doi: 10.1039/C5RA25477ARenouJDiasJMerceyGVerdeletTRousseauCGastellierA-JArboleasMTouvrey-LoiodiceMBaatiRJeanLNachonFRenardP-YSynthesis and in vitro evaluation of donepezil- based reactivators and analogues for nerve agent-inhibited human acetylcholinesterase201661792940doi10.1039/C5RA25477AOpen DOISearch in Google Scholar
de Koning MC, van Grol M, Noort D. Peripheral site ligand conjugation to a non-quaternary oxime enhances reactivation of nerve agent-inhibited human acetylcholinesterase. Toxicol Lett 2011;206:54–9. doi: 10.1016/j.toxlet.2011.04.004de KoningMCvan GrolMNoortDPeripheral site ligand conjugation to a non-quaternary oxime enhances reactivation of nerve agent-inhibited human acetylcholinesterase2011206549doi10.1016/j.toxlet.2011.04.00421504785Open DOISearch in Google Scholar
Kliachyna M, Santoni G, Nussbaum V, Renou J, Sanson B, Colletier J-P, Arboléas M, Loiodice M, Weik M, Jean L, Renard P-Y, Nachon F, Baati R. Design, synthesis and biological evaluation of novel tetrahydroacridine pyridinealdoxime and -amidoxime hybrids as efficient uncharged reactivators of nerve agent-inhibited human acetylcholinesterase. Eur J Med Chem 2014;78:455–67. doi: 10.1016/j.ejmech.2014.03.044KliachynaMSantoniGNussbaumVRenouJSansonBColletierJ-PArboléasMLoiodiceMWeikMJeanLRenardP-YNachonFBaatiRDesign, synthesis and biological evaluation of novel tetrahydroacridine pyridinealdoxime and -amidoxime hybrids as efficient uncharged reactivators of nerve agent-inhibited human acetylcholinesterase20147845567doi10.1016/j.ejmech.2014.03.04424704618Open DOISearch in Google Scholar
Renou J, Loiodice M, Arboléas M, Baati R, Jean L, Nachon F, Renard P-Y. Tryptoline-3-hydroxypyridinaldoxime conjugates as efficient reactivators of phosphylated human acetyl and butyrylcholinesterases. Chem Commun 2014;50:3947–50. doi: 10.1039/C4CC00561ARenouJLoiodiceMArboléasMBaatiRJeanLNachonFRenardP-YTryptoline-3-hydroxypyridinaldoxime conjugates as efficient reactivators of phosphylated human acetyl and butyrylcholinesterases201450394750doi10.1039/C4CC00561AOpen DOISearch in Google Scholar
Zorbaz T, Braïki A, Maraković N, Renou J, de la Mora E, Maček Hrvat N, Katalinić M, Silman I, Sussman JL, Mercey G, Gomez C, Mougeot R, Pérez B, Baati R, Nachon F, Weik M, Jean L, Kovarik Z, Renard P-Y. Potent 3-hydroxy-2-pyridine aldoxime reactivators of organophosphate-inhibited cholinesterases with predicted blood-brain barrier penetration. Chem Eur J 2018;24:9675–91. doi: 10.1002/chem.201801394ZorbazTBraïkiAMarakovićNRenouJde la MoraEMaček HrvatNKatalinićMSilmanISussmanJLMerceyGGomezCMougeotRPérezBBaatiRNachonFWeikMJeanLKovarikZRenardP-YPotent 3-hydroxy-2-pyridine aldoxime reactivators of organophosphate-inhibited cholinesterases with predicted blood-brain barrier penetration201824967591doi10.1002/chem.20180139429672968Open DOISearch in Google Scholar
Mercey G, Verdelet T, Saint-André G, Gillon E, Wagner A, Baati R, Jean L, Nachon F, Renard P-Y. First efficient uncharged reactivators for the dephosphylation of poisoned human acetylcholinesterase. Chem Commun 2011;47:5295–7. doi: 10.1039/C1CC10787AMerceyGVerdeletTSaint-AndréGGillonEWagnerABaatiRJeanLNachonFRenardP-YFirst efficient uncharged reactivators for the dephosphylation of poisoned human acetylcholinesterase20114752957doi10.1039/C1CC10787AOpen DOISearch in Google Scholar
Mercey G, Renou J, Verdelet T, Kliachyna M, Baati R, Gillon E, Arboléas M, Loiodice M, Nachon F, Jean L, Renard P-Y. Phenyltetrahydroisoquinoline-pyridinaldoxime conjugates as efficient uncharged reactivators for the dephosphylation of inhibited human acetylcholinesterase. J Med Chem 2012;55:10791–5. doi: 10.1021/jm3015519MerceyGRenouJVerdeletTKliachynaMBaatiRGillonEArboléasMLoiodiceMNachonFJeanLRenardP-YPhenyltetrahydroisoquinoline-pyridinaldoxime conjugates as efficient uncharged reactivators for the dephosphylation of inhibited human acetylcholinesterase201255107915doi10.1021/jm301551923148598Open DOISearch in Google Scholar
Kalisiak J, Ralph EC, Zhang J, Cashman JR. Amidineoximes: reactivators for organophosphate exposure. J Med Chem 2011;54:3319–30. doi: 10.1021/jm200054rKalisiakJRalphECZhangJCashmanJRAmidineoximes: reactivators for organophosphate exposure201154331930doi10.1021/jm200054r21438612Open DOISearch in Google Scholar
Sit RK, Radić Z, Gerardi V, Zhang L, Garcia E, Katalinić M, Amitai G, Kovarik Z, Fokin VV, Sharpless KB, Taylor P. New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases. J Biol Chem 2011;286:19422–30. doi: 10.1074/jbc.M111.230656SitRKRadićZGerardiVZhangLGarciaEKatalinićMAmitaiGKovarikZFokinVVSharplessKBTaylorPNew structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases20112861942230doi10.1074/jbc.M111.230656310332121464125Open DOISearch in Google Scholar
Kalisiak J, Ralph EC, Cashman JR. Nonquaternary reactivators for organophosphate-inhibited cholinesterases. J Med Chem 2012;55:465–74. doi: 10.1021/jm201364dKalisiakJRalphECCashmanJRNonquaternary reactivators for organophosphate-inhibited cholinesterases20125546574doi10.1021/jm201364d22206546Open DOISearch in Google Scholar
Radić Z, Sit RK, Kovarik Z, Berend S, Garcia E, Zhang L, Amitai G, Green C, Radić B, Fokin VV, Sharpless KB, Taylor P. Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases. J Biol Chem 2012;287:11798–809. doi: 10.1074/jbc.M111.333732RadićZSitRKKovarikZBerendSGarciaEZhangLAmitaiGGreenCRadićBFokinVVSharplessKBTaylorPRefinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases201228711798809doi10.1074/jbc.M111.333732332092822343626Open DOISearch in Google Scholar
Chambers JE, Chambers HW, Meek EC, Pringle RB. Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates. Chem Biol Interact 2013;203:135–8. doi: 10.1016/j. cbi.2012.10.017ChambersJEChambersHWMeekECPringleRBTesting of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates20132031358doi10.1016/j.cbi.2012.10.01723123249Open DOISearch in Google Scholar
Kovarik Z, Maček N, Sit RK, Radić Z, Fokin VV, Barry Sharpless K, Taylor P. Centrally acting oximes in reactivation of tabun-phosphoramidated AChE. Chem Biol Interact 2013;203:77–80. doi: 10.1016/j.cbi.2012.08.019KovarikZMačekNSitRKRadićZFokinVVBarry SharplessKTaylorPCentrally acting oximes in reactivation of tabun-phosphoramidated AChE20132037780doi10.1016/j.cbi.2012.08.019353064322960624Open DOISearch in Google Scholar
Sit RK, Kovarik Z, Maček Hrvat N, Žunec S, Green C, Fokin VV, Sharpless KB, Radić Z, Taylor P. Pharmacology, pharmacokinetics, and tissue disposition of zwitterionic hydroxyiminoacetamido alkylamines as reactivating antidotes for organophosphate exposure. J Pharmacol Exp Ther 2018;367:363–72. doi: 10.1124/jpet.118.249383SitRKKovarikZMaček HrvatNŽunecSGreenCFokinVVSharplessKBRadićZTaylorPPharmacology, pharmacokinetics, and tissue disposition of zwitterionic hydroxyiminoacetamido alkylamines as reactivating antidotes for organophosphate exposure201836736372doi10.1124/jpet.118.249383622319430190337Open DOISearch in Google Scholar
Taylor P, Yan-Jye S, Momper J, Hou W, Camacho-Hernandez GA, Radić Z, Rosenberg Y, Kovarik Z, Sit R, Sharpless KB. Assessment of ionizable, zwitterionic oximes as reactivating antidotal agents for organophosphate exposure. Chem Biol Interact 2019;308:194–7. doi: 10.1016/j.cbi.2019.05.015TaylorPYan-JyeSMomperJHouWCamacho-HernandezGARadićZRosenbergYKovarikZSitRSharplessKBAssessment of ionizable, zwitterionic oximes as reactivating antidotal agents for organophosphate exposure20193081947doi10.1016/j.cbi.2019.05.01531100277Open DOISearch in Google Scholar
Rosenberg YJ, Mao L, Jiang X, Lees J, Zhang L, Radić Z, Taylor P. Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor. Chem Biol Interact 2017;274:50–7. doi: 10.1016/j.cbi.2017.07.003RosenbergYJMaoLJiangXLeesJZhangLRadićZTaylorPPost-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor2017274507doi10.1016/j.cbi.2017.07.003558650728693885Open DOISearch in Google Scholar
Rosenberg YJ, Wang J, Ooms T, Rajendran N, Mao L, Jiang X, Lees J, Urban L, Momper JD, Sepulveda Y, Shyong YJ, Taylor P. Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques. Toxicol Lett 2018;293:229–34. doi: 10.1016/j.toxlet.2017.10.025RosenbergYJWangJOomsTRajendranNMaoLJiangXLeesJUrbanLMomperJDSepulvedaYShyongYJTaylorPPost-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques201829322934doi10.1016/j.toxlet.2017.10.025594318129129799Open DOISearch in Google Scholar
Kreuter J, Alyautdin RN, Kharkevich DA, Ivanov AA. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res 1995;674:171–4. doi: 10.1016/0006-8993(95)00023-jKreuterJAlyautdinRNKharkevichDAIvanovAAPassage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)19956741714doi10.1016/0006-8993(95)00023-jOpen DOISearch in Google Scholar
Wagner S, Kufleitner J, Zensi A, Dadparvar M, Wien S, Bungert J, Vogel T, Worek F, Kreuter J, Briesen HV. Nanoparticulate transport of oximes over an in vitro blood-brain barrier model. PLoS One 2010;5(12):e14213. doi: 10.1371/journal.pone.0014213WagnerSKufleitnerJZensiADadparvarMWienSBungertJVogelTWorekFKreuterJBriesenHVNanoparticulate transport of oximes over an in vitro blood-brain barrier model2010512e14213doi10.1371/journal.pone.0014213Open DOISearch in Google Scholar
Demar JC, Clarkson ED, Ratcliffe RH, Campbell AJ, Thangavelu SG, Herdman CA, Leader H, Schulz SM, Marek E, Medynets MA, Ku TC, Evans SA, Khan FA, Owens RR, Nambiar MP, Gordon RK. Pro-2-PAM therapy for central and peripheral cholinesterases. Chem Biol Interact 2010;187:191–8. doi: 10.1016/j.cbi.2010.02.015DemarJCClarksonEDRatcliffeRHCampbellAJThangaveluSGHerdmanCALeaderHSchulzSMMarekEMedynetsMAKuTCEvansSAKhanFAOwensRRNambiarMPGordonRKPro-2-PAM therapy for central and peripheral cholinesterases20101871918doi10.1016/j.cbi.2010.02.015Open DOISearch in Google Scholar
Jeong HC, Park NJ, Chae CH, Musilek K, Kassa J, Kuča K, Jung Y-S. Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent. Bioorg Med Chem 2009;17:6213–7. doi: 10.1016/j.bmc.2009.07.043JeongHCParkNJChaeCHMusilekKKassaJKučaKJungY-SFluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent20091762137doi10.1016/j.bmc.2009.07.043Open DOISearch in Google Scholar
Zorbaz T, Malinak D, Maraković N, Maček Hrvat N, Zandona A, Novotny M, Skarka A, Andrys R, Benkova M, Soukup O, Katalinić M, Kuca K, Kovarik Z, Musilek K. Pyridinium oximes with ortho-positioned chlorine moiety exhibit improved physicochemical properties and efficient reactivation of human acetylcholinesterase inhibited by several nerve agents. J Med Chem 2018;61:10753–66. doi: 10.1021/acs.jmedchem.8b01398ZorbazTMalinakDMarakovićNMaček HrvatNZandonaANovotnyMSkarkaAAndrysRBenkovaMSoukupOKatalinićMKucaKKovarikZMusilekKPyridinium oximes with ortho-positioned chlorine moiety exhibit improved physicochemical properties and efficient reactivation of human acetylcholinesterase inhibited by several nerve agents2018611075366doi10.1021/acs.jmedchem.8b01398Open DOISearch in Google Scholar
Joosen MJ, van der Schans MJ, van Dijk CG, Kuijpers WC, Wortelboer HM, van Helden HP. Increasing oxime efficacy by blood-brain barrier modulation. Toxicol Lett 2011;206:67–71. doi: 10.1016/j.toxlet.2011.05.231JoosenMJvan der SchansMJvan DijkCGKuijpersWCWortelboerHMvan HeldenHPIncreasing oxime efficacy by blood-brain barrier modulation20112066771doi10.1016/j.toxlet.2011.05.231Open DOISearch in Google Scholar
Heldman E, Ashani Y, Raveh L, Rachaman ES. Sugar conjugates of pyridinium aldoximes as antidotes against organophosphate poisoning. Carbohydr Res 1986;151:337–47. doi: 10.1016/s0008-6215(00)90353–7HeldmanEAshaniYRavehLRachamanESSugar conjugates of pyridinium aldoximes as antidotes against organophosphate poisoning198615133747doi10.1016/s0008-6215(00)90353–7Open DOISearch in Google Scholar
Garcia GE, Campbell AJ, Olson J, Moorad-Doctor D, Morthole VI. Novel oximes as blood-brain barrier penetrating cholinesterase reactivators. Chem Biol Interact 2010;187:199–206. doi: 10.1016/j.cbi.2010.02.033GarciaGECampbellAJOlsonJMoorad-DoctorDMortholeVINovel oximes as blood-brain barrier penetrating cholinesterase reactivators2010187199206doi10.1016/j.cbi.2010.02.03320227398Open DOISearch in Google Scholar
Eto M. Organic and biological chemistry. In: Zweig G, editor. The organophosphorus pesticides. Cleveland: CRC Press Inc; 1976. p. 142.EtoMOrganic and biological chemistryInZweigGeditorClevelandCRC Press Inc1976p142Search in Google Scholar
Cabal J, Kuca K, Kassa J. Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Basic Clin Pharmacol Toxicol 2004;95:81–6. doi: 10.1111/j.1742-7843.2004.950207.xCabalJKucaKKassaJSpecification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase200495816doi10.1111/j.1742-7843.2004.950207.x15379785Open DOISearch in Google Scholar
Čalić M, Bosak A, Kuca K, Kovarik Z. Interactions of butane, but-2-ene or xylene-like linked bispyridinium paraaldoximes with native and tabun-inhibited human cholinesterases. Chem Biol Interact 2008;175:305–8. doi: 10.1016/j.cbi.2008.04.010ČalićMBosakAKucaKKovarikZInteractions of butane, but-2-ene or xylene-like linked bispyridinium paraaldoximes with native and tabun-inhibited human cholinesterases20081753058doi10.1016/j.cbi.2008.04.01018501885Open DOISearch in Google Scholar
Artursson E, Akfur C, Hörnberg A, Worek F, Ekström F. Reactivation of tabun-hAChE investigated by structurally analogous oximes and mutagenesis. Toxicology 2009;265:108–14. doi: 10.1016/j.tox.2009.09.002ArturssonEAkfurCHörnbergAWorekFEkströmFReactivation of tabun-hAChE investigated by structurally analogous oximes and mutagenesis200926510814doi10.1016/j.tox.2009.09.00219761810Open DOISearch in Google Scholar
Kovarik Z, Čalić M, Šinko G, Bosak A. Structure-activity approach in the reactivation of tabun-phosphorylated human acetylcholinesterase with bispyridinium para-aldoximes. Arh Hig Rada Toksikol 2007;58:201–9. doi: 10.2478/v10004-007-0013-7KovarikZČalićMŠinkoGBosakAStructure-activity approach in the reactivation of tabun-phosphorylated human acetylcholinesterase with bispyridinium para-aldoximes2007582019doi10.2478/v10004-007-0013-717562604Open DOISearch in Google Scholar
Berend S, Katalinić M, Lucić Vrdoljak A, Kovarik Z, Kuca K, Radić B. In vivo experimental approach to treatment against tabun poisoning. J Enzyme Inhib Med Chem 2010;25:531–6. doi: 10.3109/14756360903357593BerendSKatalinićMLucićVrdoljak AKovarikZKucaKRadićB.In vivo experimental approach to treatment against tabun poisoning2010255316doi10.3109/1475636090335759320235800Open DOISearch in Google Scholar
Kovarik Z, Lucić Vrdoljak A, Berend S, Katalinić M, Kuča K, Musilek K, Radić B. Evaluation of oxime K203 as antidote in tabun poisoning. Arh Hig Rada Toksikol 2009;60:19–26. doi: 10.2478/10004-1254-60-2009-1890KovarikZLucić VrdoljakABerendSKatalinićMKučaKMusilekKRadićBEvaluation of oxime K203 as antidote in tabun poisoning2009601926doi10.2478/10004-1254-60-2009-189019329372Open DOISearch in Google Scholar
Elsinghorst PW, Worek F, Thiermann H, Wille T. Drug development for the management of organophosphorus poisoning. Expert Opin Drug Discov 2013;8:1467–77. doi: 10.1517/17460441.2013.847920ElsinghorstPWWorekFThiermannHWilleTDrug development for the management of organophosphorus poisoning20138146777doi10.1517/17460441.2013.84792024125474Open DOISearch in Google Scholar
Seeger T, Eichhorn M, Lindner M, Niessen KV, Tattersall JEH, Timperley CM, Bird M, Green AC, Thiermann H, Worek F. Restoration of soman-blocked neuromuscular transmission in human and rat muscle by the bispyridinium non-oxime MB327 in vitro. Toxicology 2012:294:80–4. doi: 10.1016/j.tox.2012.02.002SeegerTEichhornMLindnerMNiessenKVTattersallJEHTimperleyCMBirdMGreenACThiermannHWorekFRestoration of soman-blocked neuromuscular transmission in human and rat muscle by the bispyridinium non-oxime MB327 in vitro2012294804doi10.1016/j.tox.2012.02.00222349640Open DOISearch in Google Scholar
Turner SR, Chad JE, Price M, Timperley CM, Bird M, Green AC, Tattersall JEH. Protection against nerve agent poisoning by a noncompetitive nicotinic antagonist. Toxicol Lett 2011;206:105–11. doi: 10.1016/j.toxlet.2011.05.1035TurnerSRChadJEPriceMTimperleyCMBirdMGreenACTattersallJEHProtection against nerve agent poisoning by a noncompetitive nicotinic antagonist201120610511doi10.1016/j.toxlet.2011.05.103521641979Open DOISearch in Google Scholar
Price ME, Whitmore CL, Tattersall JEH, Green AC, Rice H. Efficacy of the antinicotinic compound MB327 against soman poisoning - Importance of experimental end point. Toxicol Lett 2018;293:167–71. doi: 10.1016/j.toxlet.2017.11.006PriceMEWhitmoreCLTattersallJEHGreenACRiceHEfficacy of the antinicotinic compound MB327 against soman poisoning - Importance of experimental end point201829316771doi10.1016/j.toxlet.2017.11.00629127032Open DOISearch in Google Scholar
Katz FS, Pecic S, Tran TH, Trakht I, Schneider L, Zhu Z, Ton-That L, Luzac M, Zlatanic V, Damera S, Macdonald J, Landry DW, Tong L, Stojanovic MN. Discovery of new classes of compounds that reactivate acetylcholinesterase inhibited by organophosphates. Chembiochem 2015;16:2205–15. doi: 10.1002/cbic.201500348KatzFSPecicSTranTHTrakhtISchneiderLZhuZTon-ThatLLuzacMZlatanicVDameraSMacdonaldJLandryDWTongLStojanovicMNDiscovery of new classes of compounds that reactivate acetylcholinesterase inhibited by organophosphates201516220515doi10.1002/cbic.201500348466417826350723Open DOISearch in Google Scholar
de Koning MC, Horn G, Worek F, van Grol M. Discovery of a potent non-oxime reactivator of nerve agent inhibited human acetylcholinesterase. Eur J Med Chem 2018;157:151–60. doi: 10.1016/j.ejmech.2018.08.016de KoningMCHornGWorekFvan GrolMDiscovery of a potent non-oxime reactivator of nerve agent inhibited human acetylcholinesterase201815715160doi10.1016/j.ejmech.2018.08.01630096649Open DOISearch in Google Scholar
Horn G, de Koning MC, van Grol M, Thiermann H, Worek F. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro. Toxicol Lett 2018;299:218–25. doi: 10.1016/j.toxlet.2018.10.004HornGde KoningMCvan GrolMThiermannHWorekFInteractions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro201829921825doi10.1016/j.toxlet.2018.10.004Open DOISearch in Google Scholar
McDonough JH Jr, Shih TM. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 1997;21:559–79. doi: 10.1016/s0149-7634(96)00050-4McDonoughJH JrShihTMNeuropharmacological mechanisms of nerve agent-induced seizure and neuropathology19972155979doi10.1016/s0149-7634(96)00050-4Open DOISearch in Google Scholar
Rump S. Convulsions in organophosphate intoxications: their mechanism and treatment. In: Sohns T, Voicu A, Szinicz L, Finke E-J, Mircioiu C, Lundy P, Brain KR, Kempf H, editors. NBC risks current capabilities and future perspectives for protection. NATO science series (Series 1: disarmament technologies). Vol 25. Dordrecht: Springer; 1999. p. 189–95.RumpSConvulsions in organophosphate intoxications: their mechanism and treatmentInSohnsTVoicuASziniczLFinkeE-JMircioiuCLundyPBrainKRKempfHeditorsVol 25DordrechtSpringer1999p1899510.1007/978-94-011-4641-8_15Search in Google Scholar
Guignet M, Lein PJ. Neuroinflammation in organophosphate-induced neurotoxicity. In: Aschner M, Costa LG, editors. Advances in neurotoxicology. Vol 3. Massachusetts: Academic Press; 2019. p. 35–79.GuignetMLeinPJNeuroinflammation in organophosphate-induced neurotoxicityInAschnerMCostaLGeditorsVol 3MassachusettsAcademic Press2019p357910.1016/bs.ant.2018.10.003Search in Google Scholar
Chen Z, Duan RS, Quezada HC, Mix E, Nennesmo I, Adem A, Winblad B, Zhu J. Increased microglial activation and astrogliosis after intranasal administration of kainic acid in C57BL/6 mice. J Neurobiol 2005;62:207–18. doi: 10.1002/neu.20099ChenZDuanRSQuezadaHCMixENennesmoIAdemAWinbladBZhuJIncreased microglial activation and astrogliosis after intranasal administration of kainic acid in C57BL/6 mice20056220718doi10.1002/neu.2009915459893Open DOISearch in Google Scholar
Banks CN, Lein PJ. A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation. Neurotoxicology 2012;33:575–84. doi: 10.1016/j.neuro.2012.02.002BanksCNLeinPJA review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation20123357584doi10.1016/j.neuro.2012.02.002335851922342984Open DOISearch in Google Scholar
Turtzo LC, Lescher J, Janes L, Dean DD, Budde MD, Frank JA. Macrophagic and microglial responses after focal traumatic brain injury in the female rat. J Neuroinflammation 2014;11:82. doi: 10.1186/1742-2094-11-82TurtzoLCLescherJJanesLDeanDDBuddeMDFrankJAMacrophagic and microglial responses after focal traumatic brain injury in the female rat20141182doi10.1186/1742-2094-11-82402236624761998Open DOISearch in Google Scholar
Becher B, Spath S, Goverman J. Cytokine networks in neuroinflammation. Nat Rev Immunol 2017;17:49–59. doi: 10.1038/nri.2016.123BecherBSpathSGovermanJCytokine networks in neuroinflammation2017174959doi10.1038/nri.2016.12327916979Open DOISearch in Google Scholar
Marrs TC. Diazepam in the treatment of organophosphorus ester pesticide poisoning. Toxicol Rev 2003;22:75–81. doi: 10.2165/00139709-200322020-00002MarrsTCDiazepam in the treatment of organophosphorus ester pesticide poisoning2003227581doi10.2165/00139709-200322020-0000215071817Open DOISearch in Google Scholar
Tattersall J. Seizure activity post organophosphate exposure. Front Biosci (Landmark Ed) 2009;14:3688–711. doi: 10.2741/3481TattersallJSeizure activity post organophosphate exposure2009143688711doi10.2741/348119273303Open DOISearch in Google Scholar
Timperley CM, Abdollahi M, Al-Amri AS, Baulig A, Benachour D, Borrett V, Cariño FA, Geist M, Gonzalez D, Kane W, Kovarik Z, Martínez-Álvarez R, Fusaro Mourão NM, Neffe S, Raza SK, Rubaylo V, Suárez AG, Takeuchi K, Tang C, Trifirò F, van Straten FM, Vanninen PS, Vučinić S, Zaitsev V, Zafar-Uz-Zaman M, Zina MS, Holen S, Forman JE, Alwan WS, Suri V. Advice on assistance and protection from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 2. On preventing and treating health effects from acute, prolonged, and repeated nerve agent exposure, and the identification of medical countermeasures able to reduce or eliminate the longer term health effects of nerve agents. Toxicology 2019;413:13–23. doi: 10.1016/j.tox.2018.11.009TimperleyCMAbdollahiMAl-AmriASBauligABenachourDBorrettVCariñoFAGeistMGonzalezDKaneWKovarikZMartínez-ÁlvarezRFusaro MourãoNMNeffeSRazaSKRubayloVSuárezAGTakeuchiKTangCTrifiròFvan StratenFMVanninenPSVučinićSZaitsevVZafar-Uz-ZamanMZinaMSHolenSFormanJEAlwanWSSuriVAdvice on assistance and protection from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 2. On preventing and treating health effects from acute, prolonged, and repeated nerve agent exposure, and the identification of medical countermeasures able to reduce or eliminate the longer term health effects of nerve agents20194131323doi10.1016/j.tox.2018.11.009Open DOISearch in Google Scholar
Aroniadou-Anderjaska V, Apland JP, Figueiredo TH, De Araujo Furtado M, Braga MF. Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: History, mechanisms of action, and medical countermeasures. Neuropharmacology 2020;181:108298. doi: 10.1016/j. neuropharm.2020.108298Aroniadou-AnderjaskaVAplandJPFigueiredoTHDe Araujo FurtadoMBragaMFAcetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: History, mechanisms of action, and medical countermeasures2020181108298doi10.1016/j.neuropharm.2020.108298Open DOISearch in Google Scholar
North Atlantic Treaty Organization (NATO). Handbook on the medical aspects of NBC defensive operations [displayed 22 November 2020]. Available at https://fas.org/nuke/guide/usa/doctrine/dod/fm8-9/3ch2.htmNorth Atlantic Treaty Organization (NATO)[displayed 22 November 2020]. Available athttps://fas.org/nuke/guide/usa/doctrine/dod/fm8-9/3ch2.htmSearch in Google Scholar
Myhrer T, Aas P. Pretreatment and prophylaxis against nerve agent poisoning: Are undesirable behavioral side effects unavoidable? Neurosci Biobehav Rev 2016;71:657–70. doi: 10.1016/j.neubiorev.2016.10.017MyhrerTAasPPretreatment and prophylaxis against nerve agent poisoning: Are undesirable behavioral side effects unavoidable?20167165770doi10.1016/j.neubiorev.2016.10.017Open DOISearch in Google Scholar
Layish I, Krivoy A, Rotman E, Finkelstein A, Tashma Z, Yehezkelli Y. Pharmacologic prophylaxis against nerve agent poisoning. Isr Med Assoc J 2005;7:182–7. PMID: 15792266LayishIKrivoyARotmanEFinkelsteinATashmaZYehezkelliY.Pharmacologic prophylaxis against nerve agent poisoning200571827PMID: 15792266Search in Google Scholar
Bajgar J, Fusek J, Kassa J, Kuca K, Jun D. Pharmacological prophylaxis against nerve agent poisoning: experimental studies and practical implications. In: Gupta RC, editor. Handbook of toxicology of chemical warfare agents. 2nd ed. Cambridge, MA: Academic Press; 2015. p. 979–87. doi: 10.1016/B978-0-12-800159-2.00066-XBajgarJFusekJKassaJKucaKJunDPharmacological prophylaxis against nerve agent poisoning: experimental studies and practical implicationsInGuptaRCeditorCambridge, MAAcademic Press2015p97987doi10.1016/B978-0-12-800159-2.00066-XOpen DOISearch in Google Scholar
Bajgar J, Fusek J, Kassa J, Kuca K, Jun D. Chemical aspects of pharmacological prophylaxis against nerve agent poisoning. Curr Med Chem 2009;16:2977–86. doi: 10.2174/092986709788803088BajgarJFusekJKassaJKucaKJunDChemical aspects of pharmacological prophylaxis against nerve agent poisoning200916297786doi10.2174/092986709788803088Open DOISearch in Google Scholar
Masson P. Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Toxicol Lett 2011;206:5–13. doi: 10.1016/j.toxlet.2011.04.006MassonPEvolution of and perspectives on therapeutic approaches to nerve agent poisoning2011206513doi10.1016/j.toxlet.2011.04.006Open DOISearch in Google Scholar
Lenz DE, Yeung D, Smith JR, Sweeney RE, Lumley LA, Cerasoli DM. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology 2007;233:31–9. doi: 10.1016/j.tox.2006.11.066LenzDEYeungDSmithJRSweeneyRELumleyLACerasoliDMStoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review2007233319doi10.1016/j.tox.2006.11.066Open DOISearch in Google Scholar
Nachon F, Brazzolotto X, Trovaslet M, Masson P. Progress in the development of enzyme-based nerve agent bioscavengers. Chem Biol Interact 2013;206:536–44. doi: 10.1016/j.cbi.2013.06.012NachonFBrazzolottoXTrovasletMMassonPProgress in the development of enzyme-based nerve agent bioscavengers201320653644doi10.1016/j.cbi.2013.06.012Open DOISearch in Google Scholar
Eckert S, Eyer P, Mückter H, Worek F. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds. Biochem Pharmacol 2006;72:344–57. doi: 10.1016/j.bcp.2006.04.015EckertSEyerPMückterHWorekFKinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds20067234457doi10.1016/j.bcp.2006.04.015Open DOISearch in Google Scholar
Gordon JJ, Leadbeater L, Maidment MP. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol Appl Pharmacol 1978;43:207–16. doi: 10.1016/s0041-008x(78)80045-3GordonJJLeadbeaterLMaidmentMPThe protection of animals against organophosphate poisoning by pretreatment with a carbamate19784320716doi10.1016/s0041-008x(78)80045-3Open DOISearch in Google Scholar
Keeler JR, Hurst CG, Dunn MA. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. JAMA 1991;266:693–5. doi: 10.1001/jama.1991.03470050093029KeelerJRHurstCGDunnMAPyridostigmine used as a nerve agent pretreatment under wartime conditions19912666935doi10.1001/jama.1991.03470050093029Open DOISearch in Google Scholar
Kassa J. Therapeutic and neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on pretreatment drug PANPAL. Arh Hig Rada Toksikol 2006;57:427–34.KassaJTherapeutic and neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on pretreatment drug PANPAL20065742734Search in Google Scholar
Golomb BA. Acetylcholinesterase inhibitors and Gulf War illnesses. Proc Natl Acad Sci U S A 2008;105:4295–300. doi: 10.1073/pnas.0711986105GolombBAAcetylcholinesterase inhibitors and Gulf War illnesses20081054295300doi10.1073/pnas.0711986105239374118332428Open DOISearch in Google Scholar
Leader H, Wolfe AD, Chiang PK, Gordon RK. Pyridophens: binary pyridostigmine-aprophen prodrugs with differential inhibition of acetylcholinesterase, butyrylcholinesterase, and muscarinic receptors. J Med Chem 2002;45:902–10. doi: 10.1021/jm010196tLeaderHWolfeADChiangPKGordonRKPyridophens: binary pyridostigmine-aprophen prodrugs with differential inhibition of acetylcholinesterase, butyrylcholinesterase, and muscarinic receptors20024590210doi10.1021/jm010196t11831902Open DOISearch in Google Scholar
Philippens IH, Joosen MJ, Vanwersch RA. Stress adversely affects efficacy of physostigmine-scopolamine pretreatment against soman in guinea pigs. Pharmacol Biochem Behav 2005;82:125–32. doi: 10.1016/j.pbb.2005.07.018PhilippensIHJoosenMJVanwerschRAStress adversely affects efficacy of physostigmine-scopolamine pretreatment against soman in guinea pigs20058212532doi10.1016/j.pbb.2005.07.01816126267Open DOISearch in Google Scholar
Aracava Y, Pereira EF, Akkerman M, Adler M, Albuquerque EX. Effectiveness of donepezil, rivastigmine, and (+/-) huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine. J Pharmacol Exp Ther 2009;331:1014–24. doi: 10.1124/jpet.109.160028AracavaYPereiraEFAkkermanMAdlerMAlbuquerqueEXEffectiveness of donepezil, rivastigmine, and (+/-) huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine2009331101424doi10.1124/jpet.109.160028278471319741148Open DOISearch in Google Scholar
Pereira EF, Aracava Y, Alkondon M, Akkerman M, Merchenthaler I, Albuquerque EX. Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning. J Mol Neurosci 2010;40:196–203. doi: 10.1007/s12031-009-9234-3PereiraEFAracavaYAlkondonMAkkermanMMerchenthalerIAlbuquerqueEXMolecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning201040196203doi10.1007/s12031-009-9234-319690988Open DOISearch in Google Scholar
Alexandrova EA, Aracava Y, Pereira EF, Albuquerque EX. Pretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampus. J Pharmacol Exp Ther 2010;334:1051–8. doi: 10.1124/jpet.110.167700AlexandrovaEAAracavaYPereiraEFAlbuquerqueEXPretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampus201033410518doi10.1124/jpet.110.167700293966720554906Open DOISearch in Google Scholar
Lucić Vrdoljak A, Čalić M, Radić B, Berend S, Jun D, Kuča K, Kovarik Z. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Toxicology 2006;228:41–50. doi: 10.1016/j.tox.2006.08.012LucićVrdoljak AČalićMRadićBBerendSJunDKučaKKovarikZPretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning20062284150doi10.1016/j.tox.2006.08.01216982122Open DOISearch in Google Scholar
Bajgar J. Complex view on poisoning with nerve agents and organophosphates. Acta Medica (Hradec Kralove) 2005;48:3–21. doi: 10.14712/18059694.2018.23BajgarJComplex view on poisoning with nerve agents and organophosphates200548321doi10.14712/18059694.2018.23Open DOISearch in Google Scholar
Maxwell DM, Brecht KM. Carboxylesterase: specificity and spontaneous reactivation of an endogenous scavenger for organophosphorus compounds. J Appl Toxicol 2001;21(Suppl 1):S103–7. doi: 10.1002/jat.833MaxwellDMBrechtKMCarboxylesterase: specificity and spontaneous reactivation of an endogenous scavenger for organophosphorus compounds200121Suppl 1S1037doi10.1002/jat.83311920929Open DOISearch in Google Scholar
Sogorb MA, Vilanova E. Serum albumins and detoxication of anti-cholinesterase agents. Chem Biol Interact 2010;187:325–9. doi: 10.1016/j.cbi.2010.03.001SogorbMAVilanovaESerum albumins and detoxication of anti-cholinesterase agents20101873259doi10.1016/j.cbi.2010.03.00120211614Open DOISearch in Google Scholar
Lockridge O. Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther 2015;148:34–46. doi: 10.1016/j.pharmthera.2014.11.011LockridgeOReview of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses20151483446doi10.1016/j.pharmthera.2014.11.01125448037Open DOISearch in Google Scholar
Doctor BP, Saxena A. Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interact 2005;157–158:167–71. doi: 10.1016/j.cbi.2005.10.024DoctorBPSaxenaABioscavengers for the protection of humans against organophosphate toxicity2005157–15816771doi10.1016/j.cbi.2005.10.02416293236Open DOISearch in Google Scholar
Kovarik Z, Maček Hrvat N. Efficient detoxification of nerve agents by oxime-assisted reactivation of acetylcholinesterase mutants. Neuropharmacology 2020;171:108111. doi: 10.1016/j.neuropharm.2020.108111KovarikZMaček HrvatNEfficient detoxification of nerve agents by oxime-assisted reactivation of acetylcholinesterase mutants2020171108111doi10.1016/j.neuropharm.2020.10811132333945Open DOISearch in Google Scholar
Liu Y, Li J, Lu Y. Enzyme therapeutics for systemic detoxification. Adv Drug Deliv Rev 2015;90:24–39. doi: 10.1016/j.addr.2015.05.005LiuYLiJLuYEnzyme therapeutics for systemic detoxification2015902439doi10.1016/j.addr.2015.05.00525980935Open DOISearch in Google Scholar
Zhang P, Jain P, Tsao C, Sinclair A, Sun F, Hung H-C, Bai T, Wu K, Jiang S. Butyrylcholinesterase nanocapsule as a long circulating bioscavenger with reduced immune response. J Control Release 2016;230:73–8. doi: 10.1016/j. jconrel.2016.04.008ZhangPJainPTsaoCSinclairASunFHungH-CBaiTWuKJiangSButyrylcholinesterase nanocapsule as a long circulating bioscavenger with reduced immune response2016230738doi10.1016/j.jconrel.2016.04.00827063423Open DOISearch in Google Scholar
Ashani Y, Pistinner S. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model. Toxicol Sci 2004;77:358–67. doi: 10.1093/toxsci/kfh012AshaniYPistinnerSEstimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model20047735867doi10.1093/toxsci/kfh01214600276Open DOISearch in Google Scholar
Saxena A, Sun W, Fedorko JM, Koplovitz I, Doctor BP. Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX. Biochem Pharmacol 2011;81:164–9. doi: 10.1016/j. bcp.2010.09.007SaxenaASunWFedorkoJMKoplovitzIDoctorBPProphylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX2011811649doi10.1016/j.bcp.2010.09.00720846507Open DOISearch in Google Scholar
Saxena A, Tipparaju P, Luo C, Doctor BP. Pilot-scale production of human serum butyrylcholinesterase suitable for use as a bioscavenger against nerve agent toxicity. Process Biochem 2010;45:1313–8. doi: 10.1016/j. procbio.2010.04.021SaxenaATipparajuPLuoCDoctorBPPilot-scale production of human serum butyrylcholinesterase suitable for use as a bioscavenger against nerve agent toxicity20104513138doi10.1016/j.procbio.2010.04.021Open DOISearch in Google Scholar
Genovese RF, Sun W, Johnson CC, Ditargiani RC, Doctor BP, Saxena A. Safety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats. Basic Clin Pharmacol Toxicol 2010;106:428–34. doi: 10.1111/j.1742-7843.2009.00508.xGenoveseRFSunWJohnsonCCDitargianiRCDoctorBPSaxenaASafety of administration of human butyrylcholinesterase and its conjugates with soman or VX in rats201010642834doi10.1111/j.1742-7843.2009.00508.x20050840Open DOISearch in Google Scholar
Čadež T, Kovarik Z. Advancements in recombinant technology for production of butyrylcholinesterase, a bioscavenger of nerve agents. Period Biol. 2020;121–122:55–63. doi: 10.18054/pb.v121i1-2.10867ČadežTKovarikZAdvancements in recombinant technology for production of butyrylcholinesterase, a bioscavenger of nerve agents2020121–1225563doi10.18054/pb.v121i1-2.10867Open DOISearch in Google Scholar
Nachon F, Nicolet Y, Viguiea N, Masson P, Fontecilla-Camps JC, Lockridge O. Engineering of a monomeric and lowglycosylated form of human butyrylcholinesterase: expression, purifcation, characterization and crystallization. Eur J Biochem 2002;269:630–7. doi: 10.1046/j.0014-2956.2001.02692.xNachonFNicoletYViguieaNMassonPFontecilla-CampsJCLockridgeOEngineering of a monomeric and lowglycosylated form of human butyrylcholinesterase: expression, purifcation, characterization and crystallization20022696307doi10.1046/j.0014-2956.2001.02692.x11856322Open DOISearch in Google Scholar
Terekhov S, Smirnov I, Bobik T, Shamborant O, Zenkova M, Chernolovskaya E, Gladkikh D, Murashev A, Dyachenko I, Paliko V, Palikova Y, Knorre V, Belogurov A Jr, Ponomarenko N, Blackburn GM, Masson P, Gabibov A. A novel expression cassette delivers efficient production of exclusively tetrameric human butyrylcholinesterase with improved pharmacokinetics for protection against organophosphate poisoning. Biochimie 2015;118:51–9. doi: 10.1016/j.biochi.2015.07.028TerekhovSSmirnovIBobikTShamborantOZenkovaMChernolovskayaEGladkikhDMurashevADyachenkoIPalikoVPalikovaYKnorreVBelogurovA JrPonomarenkoNBlackburnGMMassonPGabibovAA novel expression cassette delivers efficient production of exclusively tetrameric human butyrylcholinesterase with improved pharmacokinetics for protection against organophosphate poisoning2015118519doi10.1016/j.biochi.2015.07.02826239905Open DOISearch in Google Scholar
Brazzolotto X, Wandhammer M, Ronco C, Trovaslet M, Jean L, Lockridge O, Renard PY, Nachon F. Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure. FEBS J 2012;279:2905–16. doi: 10.1111/j.1742-4658.2012.08672.xBrazzolottoXWandhammerMRoncoCTrovasletMJeanLLockridgeORenardPYNachonFHuman butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure2012279290516doi10.1111/j.1742-4658.2012.08672.x22726956Open DOISearch in Google Scholar
Li S, Ip DT, Lin HQ, Liu JM, Miao YG, Ke LJ, Wan DC. High-level expression of functional recombinant human butyrylcholinesterase in silkworm larvae by Bac-to-Bac system. Chem Biol Interact 2010;187:101–5. doi: 10.1016/j. cbi.2010.03.055LiSIpDTLinHQLiuJMMiaoYGKeLJWanDCHigh-level expression of functional recombinant human butyrylcholinesterase in silkworm larvae by Bac-to-Bac system20101871015doi10.1016/j.cbi.2010.03.05520399761Open DOISearch in Google Scholar
Geyer BC, Kannan L, Garnaud PE, Broomfield CA, Cadieux CL, Cherni I, Hodgins SM, Kasten SA, Kelley K, Kilbourne J, Oliver ZP, Otto TC, Puffenberger I, Reeves TE, Robbins N 2nd, Woods RR, Soreq H, Lenz DE, Cerasoli DM, Mor TS. Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents. Proc Natl Acad Sci U S A 2010;107:20251–6. doi: 10.1073/pnas.1009021107GeyerBCKannanLGarnaudPEBroomfieldCACadieuxCLCherniIHodginsSMKastenSAKelleyKKilbourneJOliverZPOttoTCPuffenbergerIReevesTERobbinsN2ndWoodsRRSoreqHLenzDECerasoliDMMorTSPlant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents2010107202516doi10.1073/pnas.1009021107299664421059932Open DOISearch in Google Scholar
Egelkrout E, Hayden CA, Wales M, Walker J, Novikov B, Grimsley J, Howard J. Production of the bioscavenger butyrylcholinesterase in maize. Mol Breeding 2017;37:136. doi: 10.1007/s11032-017-0731-8EgelkroutEHaydenCAWalesMWalkerJNovikovBGrimsleyJHowardJProduction of the bioscavenger butyrylcholinesterase in maize201737136doi10.1007/s11032-017-0731-8Open DOISearch in Google Scholar
Corbin JM, Hashimoto BI, Karuppanan K, Kyser ZR, Wu L, Roberts BA, Noe AR, Rodriguez RL, McDonald KA, Nandi S. Semicontinuous bioreactor production of recombinant butyrylcholinesterase in transgenic rice cell suspension cultures. Front Plant Sci 2016;7:412. doi: 10.3389/fpls.2016.00412CorbinJMHashimotoBIKaruppananKKyserZRWuLRobertsBANoeARRodriguezRLMcDonaldKANandiSSemicontinuous bioreactor production of recombinant butyrylcholinesterase in transgenic rice cell suspension cultures20167412doi10.3389/fpls.2016.00412481450427066048Open DOISearch in Google Scholar
Huang YJ, Huang Y, Baldassarre H, Wang B, Lazaris A, Leduc M, Bilodeau AS, Bellemare A, Côté M, Herskovits P, Touati M, Turcotte C, Valeanu L, Lemée N, Wilgus H, Bégin I, Bhatia B, Rao K, Neveu N, Brochu E, Pierson J, Hockley DK, Cerasoli DM, Lenz DE, Karatzas CN, Langermann S. Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning. Proc Natl Acad Sci U S A 2007;104:13603–8. doi: 10.1073/pnas.0702756104HuangYJHuangYBaldassarreHWangBLazarisALeducMBilodeauASBellemareACôtéMHerskovitsPTouatiMTurcotteCValeanuLLeméeNWilgusHBéginIBhatiaBRaoKNeveuNBrochuEPiersonJHockleyDKCerasoliDMLenzDEKaratzasCNLangermannSRecombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning2007104136038doi10.1073/pnas.0702756104193433917660298Open DOISearch in Google Scholar
Terekhov SS, Smirnov IV, Stepanova AV, Bobik TV, Mokrushina YA, Ponomarenko NA, Belogurov AA Jr, Rubtsova MP, Kartseva OV, Gomzikova MO, Moskovtsev AA, Bukatin AS, Dubina MV, Kostryukova ES, Babenko VV, Vakhitova MT, Manolov AI, Malakhova MV, Kornienko MA, Tyakht AV, Vanyushkina AA, Ilina EN, Masson P, Gabibov AG, Altman S. Microfluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity. Proc Natl Acad Sci U S A 2017;114:2550–5. doi: 10.1073/pnas.1621226114TerekhovSSSmirnovIVStepanovaAVBobikTVMokrushinaYAPonomarenkoNABelogurovAA JrRubtsovaMPKartsevaOVGomzikovaMOMoskovtsevAABukatinASDubinaMVKostryukovaESBabenkoVVVakhitovaMTManolovAIMalakhovaMVKornienkoMATyakhtAVVanyushkinaAAIlinaENMassonPGabibovAGAltmanSMicrofluidic droplet platform for ultrahigh-throughput single-cell screening of biodiversity201711425505doi10.1073/pnas.1621226114534755428202731Open DOISearch in Google Scholar
Brazzolotto X, Igert A, Guillon V, Santoni G, Nachon F. Bacterial expression of human butyrylcholinesterase as a tool for nerve agent bioscavengers development. Molecules 2017;22:1828. doi: 10.3390/molecules22111828BrazzolottoXIgertAGuillonVSantoniGNachonFBacterial expression of human butyrylcholinesterase as a tool for nerve agent bioscavengers development2017221828doi10.3390/molecules22111828615035429077024Open DOISearch in Google Scholar
Gupta V, Cadieux LC, Mcmenamin D, Medina-Jaszek CA, Arif M, Ahonkhai O, Wielechowski E, Taheri M, Che Y, Goode T, Limberis MP, Li M, Cerasoli DM, Tretiakova AP, Wilson JM. Adeno-associated virus-mediated expression of human butyrylcholinesterase to treat organophosphate poisoning. PLoS One 2019;14(11):e0225188. doi: 10.1371/journal.pone.0225188GuptaVCadieuxLCMcmenaminDMedina-JaszekCAArifMAhonkhaiOWielechowskiETaheriMCheYGoodeTLimberisMPLiMCerasoliDMTretiakovaAPWilsonJMAdeno-associated virus-mediated expression of human butyrylcholinesterase to treat organophosphate poisoning20191411e0225188doi10.1371/journal.pone.0225188687693431765413Open DOISearch in Google Scholar
Lockridge O, David E, Schopfer LM, Masson P, Brazzolotto X, Nachon F. Purification of recombinant human butyrylcholinesterase on Hupresin® J Chromatogr B 2018;1102–1103:109–15. doi: 10.1016/j. jchromb.2018.10.026LockridgeODavidESchopferLMMassonPBrazzolottoXNachonFPurification of recombinant human butyrylcholinesterase on Hupresin®20181102–110310915doi10.1016/j.jchromb.2018.10.026627510430384187Open DOISearch in Google Scholar
Larson MA, Lockridge O, Hinrichs SH. Polyproline promotes tetramerization of recombinant human butyrylcholinesterase. Biochem J 2014;462:329–35. doi: 10.1042/BJ20140421LarsonMALockridgeOHinrichsSHPolyproline promotes tetramerization of recombinant human butyrylcholinesterase201446232935doi10.1042/BJ2014042124916051Open DOISearch in Google Scholar
Rosenberg YJ, Saxena A, Sun W, Jiang X, Chilukuri N, Luo C, Doctor BP, Lee KD. Demonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycolconjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model. Chem Biol Interact 2010;187:279–86. doi: 10.1016/j.cbi.2010.02.042RosenbergYJSaxenaASunWJiangXChilukuriNLuoCDoctorBPLeeKDDemonstration of in vivo stability and lack of immunogenicity of a polyethyleneglycolconjugated recombinant CHO-derived butyrylcholinesterase bioscavenger using a homologous macaque model201018727986doi10.1016/j.cbi.2010.02.04220211615Open DOISearch in Google Scholar
Terekhov SS, Smirnov IV, Shamborant OG, Bobik TV, Ilyushin DG, Murashev AN, Dyachenko IA, Palikov VA, Knorre VD, Belogurov AA, Ponomarenko NA, Kuzina ES, Genkin DD, Masson P, Gabibov AG. Chemical polysialylation and in vivo tetramerization improve pharmacokinetic characteristics of recombinant human butyrylcholinesterase-based bioscavengers. Acta Naturae 2015;7:136–41. doi: 10.32607/20758251-2015-7-4-136-141TerekhovSSSmirnovIVShamborantOGBobikTVIlyushinDGMurashevANDyachenkoIAPalikovVAKnorreVDBelogurovAAPonomarenkoNAKuzinaESGenkinDDMassonPGabibovAG. Chemical polysialylation andin vivo tetramerization improve pharmacokinetic characteristics of recombinant human butyrylcholinesterase-based bioscavengers2015713641doi10.32607/20758251-2015-7-4-136-141Open DOISearch in Google Scholar
Huang YJ, Lundy PM, Lazaris A, Huang Y, Baldassarre H, Wang B, Turcotte C, Côté M, Bellemare A, Bilodeau AS, Brouillard S, Touati M, Herskovits P, Bégin I, Neveu N, Brochu E, Pierson J, Hockley DK, Cerasoli DM, Lenz DE, Wilgus H, Karatzas CN, Langermann S. Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin. BMC Biotechnol 2008;8:50. doi: 10.1186/1472-6750-8-50HuangYJLundyPMLazarisAHuangYBaldassarreHWangBTurcotteCCôtéMBellemareABilodeauASBrouillardSTouatiMHerskovitsPBéginINeveuNBrochuEPiersonJHockleyDKCerasoliDMLenzDEWilgusHKaratzasCNLangermannSSubstantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin2008850doi10.1186/1472-6750-8-50241518018485214Open DOISearch in Google Scholar
Ilyushin DG, Smirnov IV, Belogurov AA Jr, Dyachenko IA, Zharmukhamedova TIu, Novozhilova TI, Bychikhin EA, Serebryakova MV, Kharybin ON, Murashev AN, Anikienko KA, Nikolaev EN, Ponomarenko NA, Genkin DD, Blackburn GM, Masson P, Gabibov AG. Chemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo. Proc Natl Acad Sci U S A 2013;110:1243–8. doi: 10.1073/pnas.1211118110IlyushinDGSmirnovIVBelogurovAA JrDyachenkoIAZharmukhamedovaTIuNovozhilovaTIBychikhinEASerebryakovaMVKharybinONMurashevANAnikienkoKANikolaevENPonomarenkoNAGenkinDDBlackburnGMMassonPGabibovAGChemical polysialylation of human recombinant butyrylcholinesterase delivers a long-acting bioscavenger for nerve agents in vivo201311012438doi10.1073/pnas.1211118110355708223297221Open DOISearch in Google Scholar
Atsmon J, Brill-Almon E, Nadri-Shay C, Chertkoff R, Alon S, Shaikevich D, Volokhov I, Haim KY, Bartfeld D, Shulman A, Ruderfer I, Ben-Moshe T, Shilovitzky O, Soreq H, Shaaltiel Y. Preclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R. Toxicol Appl Pharmacol 2015;287:202–9. doi: 10.1016/j.taap.2015.06.004AtsmonJBrill-AlmonENadri-ShayCChertkoffRAlonSShaikevichDVolokhovIHaimKYBartfeldDShulmanARuderferIBen-MosheTShilovitzkyOSoreqHShaaltielYPreclinical and first-in-human evaluation of PRX-105, a PEGylated, plant-derived, recombinant human acetylcholinesterase-R20152872029doi10.1016/j.taap.2015.06.00426051873Open DOISearch in Google Scholar
Pascual L, Sayed SE, Martínez-Máñez R, Costero AM, Gil S, Gavina P, Sancenon F. Acetylcholinesterase-capped mesoporous silica nanoparticles that open in the presence of Maček Hrvat N, Kovarik Z. Counteracting poisoning with chemical warfare nerve agents Arh Hig Rada Toksikol 2020;71:266-284 diisopropylfluorophosphate (a sarin or soman simulant). Org Lett 2016;18:5548–51. doi: 10.1021/acs.orglett.6b02793PascualLSayedSEMartínez-MáñezRCosteroAMGilSGavinaPSancenonFAcetylcholinesterase-capped mesoporous silica nanoparticles that open in the presence of Maček Hrvat N, Kovarik Z202071266284diisopropylfluorophosphate (a sarin or soman simulant). Org Lett 2016;18:5548–51. doi10.1021/acs.orglett.6b0279327754682Open DOISearch in Google Scholar
Cohen O, Kronman C, Raveh L, Mazor O, Ordentlich A, Shafferman A. Comparison of polyethylene glycolconjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds. Mol Pharmacol 2006;70:1121–31. doi: 10.1124/mol.106.026179CohenOKronmanCRavehLMazorOOrdentlichAShaffermanAComparison of polyethylene glycolconjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds200670112131doi10.1124/mol.106.02617916801396Open DOISearch in Google Scholar
Masson P, Nachon F, Broomfield CA, Lenz DE, Verdier L, Schopfer LM, Lockridge O. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters. Chem Biol Interact 2008;175:273–80. doi: 10.1016/j.cbi.2008.04.005MassonPNachonFBroomfieldCALenzDEVerdierLSchopferLMLockridgeOA collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters200817527380doi10.1016/j.cbi.2008.04.00518508040Open DOISearch in Google Scholar
Cochran R, Kalisiak J, Küçükkilinç, T, Radić Z, Garcia E, Zhang L, Ho KY, Amitai G, Kovarik Z, Fokin VV, Sharpless KB, Taylor P. Oxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging. J Biol Chem 2011;286:29718–24. doi: 10.1074/jbc.M111.264739CochranRKalisiakJKüçükkilinçTRadićZGarciaEZhangLHoKYAmitaiGKovarikZFokinVVSharplessKBTaylorPOxime-assisted acetylcholinesterase catalytic scavengers of organophosphates that resist aging20112862971824doi10.1074/jbc.M111.264739319101321730071Open DOISearch in Google Scholar
Horn G, Wille T, Musilek K, Kuca K, Thiermann H, Worek F. Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase. Arch Toxicol 2015;89:405–14. doi: 10.1007/s00204-014-1288-5HornGWilleTMusilekKKucaKThiermannHWorekFReactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase20158940514doi10.1007/s00204-014-1288-524912784Open DOISearch in Google Scholar
Radić Z, Dale T, Kovarik Z, Berend S, Garcia E, Zhang L, Amitai G, Green C, Radić B, Duggan BM, Ajami D, Rebek J, Taylor P. Catalytic detoxification of nerve agent and pesticide organophosphates by butyrylcholinesterase assisted with non-pyridinium oximes. Biochem J 2013;450:231–42. doi: 10.1042/BJ20121612RadićZDaleTKovarikZBerendSGarciaEZhangLAmitaiGGreenCRadićBDugganBMAjamiDRebekJTaylorPCatalytic detoxification of nerve agent and pesticide organophosphates by butyrylcholinesterase assisted with non-pyridinium oximes201345023142doi10.1042/BJ20121612477267323216060Open DOISearch in Google Scholar
Sit RK, Fokin VV, Amitai G, Sharpless KB, Taylor P, Radić Z. Imidazole aldoximes effective in assisting butyrylcholinesterase catalysis of organophosphate detoxification. J Med Chem 2014;57:1378–89. doi: 10.1021/jm401650zSitRKFokinVVAmitaiGSharplessKBTaylorPRadićZImidazole aldoximes effective in assisting butyrylcholinesterase catalysis of organophosphate detoxification201457137889doi10.1021/jm401650z416706824571195Open DOISearch in Google Scholar
Bušić V, Katalinić M, Šinko G, Kovarik Z, Gašo-Sokač D. Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds. Toxicol Lett 2016;262:114–22. doi: 10.1016/j. toxlet.2016.09.015BušićVKatalinićMŠinkoGKovarikZGašo-SokačDPyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds201626211422doi10.1016/j.toxlet.2016.09.01527693733Open DOISearch in Google Scholar
Katalinić M, Maček Hrvat N, Baumann K, Morasi Piperčić S, Makarić S, Tomić S, Jović O, Hrenar T, Miličević A, Jelić D, Žunec S, Primožič I, Kovarik Z. A comprehensive evaluation of novel oximes in creation of butyrylcholinesterase-based nerve agent bioscavengers. Toxicol Appl Pharmacol 2016;310:195–204. doi: 10.1016/j.taap.2016.09.015KatalinićMMaček HrvatNBaumannKMorasi PiperčićSMakarićSTomićSJovićOHrenarTMiličevićAJelićDŽunecSPrimožičIKovarikZA comprehensive evaluation of novel oximes in creation of butyrylcholinesterase-based nerve agent bioscavengers2016310195204doi10.1016/j.taap.2016.09.01527654152Open DOISearch in Google Scholar
Katalinić M, Zandona A, Ramić A, Zorbaz T, Primožič I, Kovarik Z. New cinchona oximes evaluated as reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by organophosphorus compounds. Molecules 2017;22(7):1234. doi: 10.3390/molecules22071234KatalinićMZandonaARamićAZorbazTPrimožičIKovarikZNew cinchona oximes evaluated as reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by organophosphorus compounds20172271234doi10.3390/molecules22071234615198928737687Open DOISearch in Google Scholar
Zorbaz T, Malinak D, Kuca K, Musilek K, Kovarik Z. Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes. Chem Biol Interact 2019;307:16–20. doi: 10.1016/j.cbi.2019.04.020ZorbazTMalinakDKucaKMusilekKKovarikZButyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes20193071620doi10.1016/j.cbi.2019.04.02031004594Open DOISearch in Google Scholar
Kovarik Z, Radić Z, Berman HA, Simeon-Rudolf V, Reiner E, Taylor P. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates. Biochem J 2003;373:33–40. doi: 10.1042/BJ20021862KovarikZRadićZBermanHASimeon-RudolfVReinerETaylorPAcetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates20033733340doi10.1042/BJ20021862Open DOISearch in Google Scholar
Katalinić M, Šinko G, Maček Hrvat N, Zorbaz T, Bosak A, Kovarik Z. Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations. Toxicology 2018;406–407:104–13. doi: 10.1016/j. tox.2018.05.008KatalinićMŠinkoGMaček HrvatNZorbazTBosakAKovarikZOxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations2018406–40710413doi10.1016/j.tox.2018.05.008Open DOISearch in Google Scholar
Kovarik Z, Radić Z, Berman HA, Taylor P. Mutation of acetylcholinesterase to enhance oxime-assisted catalytic turnover of methylphosphonates. Toxicology 2007;233:79–84. doi: 10.1016/j.tox.2006.08.032KovarikZRadićZBermanHATaylorPMutation of acetylcholinesterase to enhance oxime-assisted catalytic turnover of methylphosphonates20072337984doi10.1016/j.tox.2006.08.032Open DOISearch in Google Scholar
Taylor P, Kovarik Z, Reiner E, Radić Z. Acetylcholinesterase: converting a vulnerable target to a template for antidotes and detection of inhibitor exposure. Toxicology 2007;233:70–8. doi: 10.1016/j.tox.2006.11.061TaylorPKovarikZReinerERadićZAcetylcholinesterase: converting a vulnerable target to a template for antidotes and detection of inhibitor exposure2007233708doi10.1016/j.tox.2006.11.061Open DOISearch in Google Scholar
Katalinić M, Kovarik Z. Reactivation of tabun-inhibited acetylcholinesterase investigated by two oximes and mutagenesis. Croat Chem Acta 2012;85:209–12. doi: 10.5562/cca1815KatalinićMKovarikZReactivation of tabun-inhibited acetylcholinesterase investigated by two oximes and mutagenesis20128520912doi10.5562/cca1815Open DOISearch in Google Scholar
Kovarik Z, Maček Hrvat N, Žunec S, Katalinić M. Detoxification of tabun-exposed mice by an acetylcholinesterase mutant assisted with a novel pyridinium aldoxime. BiIol Serb 2019;41:4–8. doi: 10.5281/zenodo.3532038KovarikZMaček HrvatNŽunecSKatalinićMDetoxification of tabun-exposed mice by an acetylcholinesterase mutant assisted with a novel pyridinium aldoxime20194148doi10.5281/zenodo.3532038Open DOISearch in Google Scholar
Mazor O, Cohen O, Kronman C, Raveh L, Stein D, Ordentlich A, Shafferman A. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase. Mol Pharmacol 2008;74:755–63. doi: 10.1124/mol.108.047449MazorOCohenOKronmanCRavehLSteinDOrdentlichAShaffermanAAging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase20087475563doi10.1124/mol.108.047449Open DOISearch in Google Scholar
Kronman C, Cohen O, Mazor O, Ordentlich A, Raveh L, Velan B, Shafferman A. Next generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338AHuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics. Chem Biol Interact 2010;187:253–8. doi: 10.1016/j.cbi.2009.12.004KronmanCCohenOMazorOOrdentlichARavehLVelanBShaffermanANext generation OP-bioscavengers: a circulatory long-lived 4-PEG hypolysine mutant of F338AHuAChE with optimal pharmacokinetics and pseudo-catalytic characteristics20101872538doi10.1016/j.cbi.2009.12.004Open DOISearch in Google Scholar
Maček Hrvat N, Žunec S, Taylor P, Radić Z, Kovarik Z. HI-6 assisted catalytic scavenging of VX by acetylcholinesterase choline binding site mutants. Chem Biol Interact 2016;259:148–53. doi: 10.1016/j.cbi.2016.04.023Maček HrvatNŽunecSTaylorPRadićZKovarikZHI-6 assisted catalytic scavenging of VX by acetylcholinesterase choline binding site mutants201625914853doi10.1016/j.cbi.2016.04.023Open DOISearch in Google Scholar
Sweeney RE, Maxwell DM. A theoretical expression for the protection associated with stoichiometric and catalytic scavengers in a single compartment model of organophosphorus poisoning. Math Biosci 2003;181:133–43. doi: 10.1016/s0025-5564(02)00154-2SweeneyREMaxwellDMA theoretical expression for the protection associated with stoichiometric and catalytic scavengers in a single compartment model of organophosphorus poisoning200318113343doi10.1016/s0025-5564(02)00154-2Open DOISearch in Google Scholar
Ashani Y, Leader H, Aggarwal N, Silman I, Worek F, Sussman JL, Goldsmith M. In vitro evaluation of the catalytic activity of paraoxonases and phosphotriesterases predicts the enzyme circulatory levels required for in vivo protection against organophosphate intoxications. Chem Biol Interact 2016;259:252–6. doi: 10.1016/j.cbi.2016.04.039AshaniYLeaderHAggarwalNSilmanIWorekFSussmanJLGoldsmithM.In vitro evaluation of the catalytic activity of paraoxonases and phosphotriesterases predicts the enzyme circulatory levels required for in vivo protection against organophosphate intoxications20162592526doi10.1016/j.cbi.2016.04.039509789127163850Open DOISearch in Google Scholar
Rochu D, Chabrière E, Masson P. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology 2007;233:47–59. doi: 10.1016/j.tox.2006.08.037RochuDChabrièreEMassonPHuman paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning20072334759doi10.1016/j.tox.2006.08.03717007987Open DOISearch in Google Scholar
Bosak A, Bavec A, Konte T, Šinko G, Kovarik Z, Goličnik M. Interactions of paraoxonase-1 with pharmacologically relevant carbamates. Molecules 2020;25:1–15. doi: 10.3390/molecules25010211BosakABavecAKonteTŠinkoGKovarikZGoličnikMInteractions of paraoxonase-1 with pharmacologically relevant carbamates202025115doi10.3390/molecules25010211698307331947900Open DOISearch in Google Scholar
Kirby SD, Norris J, Sweeney R, Bahnson BJ, Cerasoli DM. A rationally designed mutant of plasma platelet-activating factor acetylhydrolase hydrolyzes the organophosphorus nerve agent soman. Biochim Biophys Acta 2015;1854:1809–15. doi: 10.1016/j.bbapap.2015.09.001KirbySDNorrisJSweeneyRBahnsonBJCerasoliDMA rationally designed mutant of plasma platelet-activating factor acetylhydrolase hydrolyzes the organophosphorus nerve agent soman20151854180915doi10.1016/j.bbapap.2015.09.001463284026343853Open DOISearch in Google Scholar
Hemmert AC, Otto TC, Wierdl M, Edwards CC, Fleming CD, MacDonald M, Cashman JR, Potter PM, Cerasoli DM, Redinbo MR. Human carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarin. Mol Pharmacol 2010;77:508–16. doi: 10.1124/mol.109.062356HemmertACOttoTCWierdlMEdwardsCCFlemingCDMacDonaldMCashmanJRPotterPMCerasoliDMRedinboMRHuman carboxylesterase 1 stereoselectively binds the nerve agent cyclosarin and spontaneously hydrolyzes the nerve agent sarin20107750816doi10.1124/mol.109.062356284594120051531Open DOISearch in Google Scholar
Yeung DT, Smith JR, Sweeney RE, Lenz DE, Cerasoli DM. A gas chromatographic-mass spectrometric approach to examining stereoselective interaction of human plasma proteins with soman. J Anal Toxicol 2008;32:86–91. doi: 10.1093/jat/32.1.86YeungDTSmithJRSweeneyRELenzDECerasoliDMA gas chromatographic-mass spectrometric approach to examining stereoselective interaction of human plasma proteins with soman2008328691doi10.1093/jat/32.1.8618269799Open DOISearch in Google Scholar
Valiyaveettil M, Alamneh Y, Biggemann L, Soojhawon I, Doctor BP, Nambiar MP. Efficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1. Biochem Biophys Res Commun 2010;403:97–102. doi: 10.1016/j.bbrc.2010.10.125ValiyaveettilMAlamnehYBiggemannLSoojhawonIDoctorBPNambiarMPEfficient hydrolysis of the chemical warfare nerve agent tabun by recombinant and purified human and rabbit serum paraoxonase 1201040397102doi10.1016/j.bbrc.2010.10.12521040699Open DOISearch in Google Scholar
Worek F, Seeger T, Goldsmith M, Ashani Y, Leader H, Sussman JS, Tawfik D, Thiermann H, Wille T. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro. Arch Toxicol 2014;88:1257–66. doi: 10.1007/s00204-014-1204-zWorekFSeegerTGoldsmithMAshaniYLeaderHSussmanJSTawfikDThiermannHWilleTEfficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro201488125766doi10.1007/s00204-014-1204-z24477626Open DOISearch in Google Scholar
Masson P, Rochu D. Catalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings. Acta Naturae 2009;1:68–79. PMCID: PMC3347506MassonPRochuDCatalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings200916879PMCID: PMC334750610.32607/20758251-2009-1-1-68-79Search in Google Scholar
Bigley AN, Xu C, Henderson TJ, Harvey SP, Raushel FM. Enzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis. J Am Chem Soc 2013;135:10426–32. doi: 10.1021/ja402832zBigleyANXuCHendersonTJHarveySPRaushelFMEnzymatic neutralization of the chemical warfare agent VX: evolution of phosphotriesterase for phosphorothiolate hydrolysis20131351042632doi10.1021/ja402832z374722823789980Open DOISearch in Google Scholar
Goldsmith M, Eckstein S, Ashani Y, Greisen P Jr, Leader H, Sussman JL, Aggarwal N, Ovchinnikov S, Tawfik DS, Baker D, Thiermann H, Worek F. Catalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro. Arch Toxicol 2016;90:2711–24. doi: 10.1007/s00204-015-1626-2GoldsmithMEcksteinSAshaniYGreisenP JrLeaderHSussmanJLAggarwalNOvchinnikovSTawfikDSBakerDThiermannHWorekFCatalytic efficiencies of directly evolved phosphotriesterase variants with structurally different organophosphorus compounds in vitro201690271124doi10.1007/s00204-015-1626-226612364Open DOISearch in Google Scholar
Smirnov I, Belogurov A Jr, Friboulet A, Masson P, Gabibov A, Renard PY. Strategies for the selection of catalytic antibodies against organophosphorus nerve agents. Chem Biol Interact 2013;203:196–201. doi: 10.1016/j. cbi.2012.10.011SmirnovIBelogurovA JrFribouletAMassonPGabibovARenardPYStrategies for the selection of catalytic antibodies against organophosphorus nerve agents2013203196201doi10.1016/j.cbi.2012.10.01123123255Open DOISearch in Google Scholar
Letort S, Balieu S, Erb W, Gouhier G, Estour F. Interactions of cyclodextrins and their derivatives with toxic organophosphorus compounds. Beilstein J Org Chem 2016;12:204–28. doi: 10.3762/bjoc.12.23LetortSBalieuSErbWGouhierGEstourFInteractions of cyclodextrins and their derivatives with toxic organophosphorus compounds20161220428doi10.3762/bjoc.12.23477850026977180Open DOISearch in Google Scholar
Taylor PW, Lukey BJ, Clark CR, Lee RB, Roussel RR. Field verification of Test-mate ChE. Mil Med 2003;168:314–9. PMID: 12733677TaylorPWLukeyBJClarkCRLeeRBRousselRRField verification of Test-mate ChE20031683149PMID: 1273367710.1093/milmed/168.4.314Search in Google Scholar
Worek F, Baumann M, Pfeiffer B, Aurbek N, Balszuweit F, Thiermann H. Cholinesterase kit for field diagnosis of organophosphate exposure. CBRN Medical Defense International 2013 [displayed 13 November 2020]. Available at https://www.securetec.net/wp-content/uploads/2018/08/Challenge_ChE_check_mobile_Special_2013.pdfWorekFBaumannMPfeifferBAurbekNBalszuweitFThiermannHCholinesterase kit for field diagnosis of organophosphate exposure2013[displayed 13 November 2020]. Available athttps://www.securetec.net/wp-content/uploads/2018/08/Challenge_ChE_check_mobile_Special_2013.pdfSearch in Google Scholar
Moshiri M, Darchini-Maragheh E, Balali-Mood M. Advances in toxicology and medical treatment of chemical warfare nerve agents. Daru 2012;20(1):81. doi: 10.1186/2008-2231-20-81MoshiriMDarchini-MaraghehEBalali-MoodMAdvances in toxicology and medical treatment of chemical warfare nerve agents201220181doi10.1186/2008-2231-20-81355604123351280Open DOISearch in Google Scholar
Timperley CM, Forman JE, Abdollahi M, Al-Amri AS, Baulig A, Benachour D, Borrett V, Cariño FA, Geist M, Gonzalez D, Kane W, Kovarik Z, Martínez-Álvarez R, Mourão NMF, Neffe S, Raza SK, Rubaylo V, Suárez AG, Takeuchi K, Tang C, Trifirò F, van Straten FM, Vanninen PS, Vučinić S, Zaitsev V, Zafar-Uz-Zaman M, Zina MS, Holen S. Advice on assistance and protection provided by the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 1. On medical care and treatment of injuries from nerve agents. Toxicology 2019;415:56–69. doi: 10.1016/j.tox.2019.01.004TimperleyCMFormanJEAbdollahiMAl-AmriASBauligABenachourDBorrettVCariñoFAGeistMGonzalezDKaneWKovarikZMartínez-ÁlvarezRMourãoNMFNeffeSRazaSKRubayloVSuárezAGTakeuchiKTangCTrifiròFvan StratenFMVanninenPSVučinićSZaitsevVZafar-Uz-ZamanMZinaMSHolenSAdvice on assistance and protection provided by the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 1. On medical care and treatment of injuries from nerve agents20194155669doi10.1016/j.tox.2019.01.00430639304Open DOISearch in Google Scholar
Thiermann H, Aurbek N, Worek F. Treatment of nerve agent poisoning. In: Worek F, Jenner J, Thiermann H, editors. Chemical warfare toxicology: Volume 2: Management of poisoning. London: The Royal Society of Chemistry; 2016. p. 1–42.ThiermannHAurbekNWorekFTreatment of nerve agent poisoningInWorekFJennerJThiermannHeditorsLondonThe Royal Society of Chemistry2016p14210.1039/9781782628071-00001Search in Google Scholar
Bentur Y, Layish I, Krivoy A, Berkovitch M, Rotman E, Bar Haim S, Yehezkelli Y, Kozer E. Civilian adult self injections of atropine-trimedoxime (TMB4) auto-injectors. Clin Toxicol (Phila) 2006;44:301–6. doi: 10.1080/15563650600584519BenturYLayishIKrivoyABerkovitchMRotmanEBar HaimSYehezkelliYKozerECivilian adult self injections of atropine-trimedoxime (TMB4) auto-injectors2006443016doi10.1080/1556365060058451916749549Open DOISearch in Google Scholar
Marrs TC, Rice P, Vale JA. The role of oximes in the treatment of nerve agent poisoning in civilian casualties. Toxicol Rev 2006;25:297–323. doi: 10.2165/00139709-200625040-00009MarrsTCRicePValeJAThe role of oximes in the treatment of nerve agent poisoning in civilian casualties200625297323doi10.2165/00139709-200625040-0000917288500Open DOISearch in Google Scholar
Koller M, Becker C, Thiermann H, Worek F. GC-MS and LC-MS analysis of nerve agents in body fluids: intra-laboratory verification test using spiked plasma and urine samples. J Chromatogr B 2010;878:1226–33. doi: 10.1016/j. jchromb.2009.12.023KollerMBeckerCThiermannHWorekFGC-MS and LC-MS analysis of nerve agents in body fluids: intra-laboratory verification test using spiked plasma and urine samples2010878122633doi10.1016/j.jchromb.2009.12.02320061191Open DOISearch in Google Scholar